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PREFACE

The following document is in partial fulfillment of the Doctor of Philosophy
degree. I believe this is true; no single document could contain all of the
components which measure an individuals worthiness to receive such a degree, if
such can be measured. I believe an individuals’ philosophy is made up of
experiences as well as higher-learning. Certainly, just as knowledge o f a particular
field is learned, a person’s philosophy is also learned to a certain extent. The
components of my philosophy begin with God, my creator. Secondly, my mom and
dad, who taught me to work hard physically and mentally, have influenced my
philosophy of life. The words from Ecclesiastes 9:10,“Whatsoever thy hand findeth
to do, do it with thy might; for there is no work, nor device, nor knowledge, nor
wisdom, in the grave, whither thou goest”, have special meaning to me. On a
lighter side, other occurrences and experiences have also influenced my philosophy.
One o f the things I try to remember occasionally is the world according to Freddy
from Jimmy Buffett’s Tales Fmm M argaritaville (pg 185). Lesson One: Never
forget—they are always the enemy. Lesson Two: Just remember, [some people] are
bom that way, and they usually don’t change. Lesson Three: You do not want to go
to jail. Lesson Four: When you start to take this job seriously, you’re in trouble.
Lesson Five: It takes more time to see the good side of life than it takes to see the
bad. Lesson Six: If you decide to run with the ball, just count on fumbling and
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getting the [stuffing] knocked out of you a lot, but never forget how much fun it is
just to be able to run with the ball. Although I consider myself to be more refined
than Freddy, the crude words do not discount their truthfulness in life. May the
following document be just another component of the lifelong development of my
philosophy and perhaps someone else’s as well.
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ABSTRACT
Three experiments were conducted with pigs and four experiments were
conducted with chickens to determine the effects of supplemental dietary Cr on
growth performance, carcass characteristics, tissue minerals and plasma metabolite
and hormone concentrations. In pigs (Exp. 1) 200 ppb Cr from seven different
sources tended to decrease growth performance during the grower phase and
increase growth performance during the finisher phase. Dietary Cr had minimal
effects on plasma metabolite and hormone concentrations and Cr did not affect
carcass characteristics. In general, dietary Cr increased tissue Cr concentration,
except for longissimus muscle (LM). In Exp. 2, pigs were fed 400 ppb Cr as Cr
chloride, Cr nicotmate, or Cr picolinate (CrPic) to determine the effect of these Cr
sources on i.v. glucose tolerance and insulin sensitivity. None of the Cr sources
affected glucose clearance rate or half-life, or insulin clearance rate or half-life. In
Exp. 3, the interactive effects of two levels o f dietary lysine, two levels of dietary
Cr, and two levels o f pen space were evaluated. During the finisher phase, Cr
increased average daily gain and gain/feed o f pigs fed 80% of the lysine requirement
but not in pigs fed 120% of the lysine requirement. In addition, Cr decreased tenth
rib fat thickness (TRF) in pigs given adequate pen space but increased TRF of pigs
given inadequate pen space. Dietary Cr supplementation did not affect LM area.
Three experiments were conducted to determine the effect of CrPic on growth
performance, plasma metabolites and hormones, and carcass composition of
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broilers. In broilers fed CrPic for two weeks, Cr decreased percentage of dry
matter of the carcass and tended to decrease percentage carcass fat. In broilers fed
CrPic for four weeks, Cr supplementation increased ventriculus weight and
increased carcass ash percentage. In broilers fed CrPic for seven weeks, Cr
decreased abdominal fat pad weight. Dietary Cr had minimal effects on plasma
metabolites and hormones in broilers. In a fourth experiment with broilers, CrPic
did not affect glucose tolerance or insulin sensitivity. Under the conditions of these
experiments dietary Cr did not affect body composition and metabolism of pigs and
broilers.

CHAPTER I
INTRODUCTION
Dietary chromium (Cr) has been reported to have beneficial effects in many
aspects o f the metabolism of man and animals. Chromium is believed to function by
facilitating the action of insulin. Some of the historic findings in Cr nutrition
include improvements in glucose tolerance and insulin sensitivity, as well as plasma
lipid status, in man and animals. Recently some researchers have reported dramatic
improvements in body composition o f growing-finishing pigs that were fed Cr
tripicolinate (CrPic), an organic source of Cr, but not pigs that were fed Cr chloride
(CrCl), an inorganic source of Cr. Specifically, these researchers have reported
increased longissimus muscle area and decreased tenth rib fat thickness in pigs fed
CrPic. Other researchers have reported increased clearance rate of glucose in pigs
fed CrPic.
Additional research, primarily in ruminants, suggests that Cr improves the
immune status of livestock. This research indicated that it was necessary for an
animal to be stressed to elicit a response to Cr supplementation. If Cr is to become
a feed additive for the feed industry in the United States (Cr is approved for use in
some foreign countries), then the specific conditions (environment, etc.) in which Cr
is beneficial to the animal need to be characterized. In addition, forms o f Cr
(organic and inorganic) other than CrPic and CrCl need to be evaluated. Therefore,
the following experiments were conducted to evaluate the effects of form of Cr and

environmental stress (decreased pen size) on growth performance, carcass
characteristics, and metabolic status of growing-finishing pigs. In addition,
experiments also were conducted to evaluate the effect of CrPic in broiler diets
growth performance, body composition, and glucose tolerance and insulin
sensitivity.

CHAPTER n
REVIEW OF LITERATURE

Introduction
There have been many excellent reviews (Anderson, 1981, 1986, 1989;
Ducros, 1992; Hambidge, 1974; Mertz 1969, 1993; M ertzetal., 1974; Offenbacher
and Pi-Sunyer, 1988; Saner, 1986; Wallach, 1985) and book chapters (Anderson,
1987; Anderson, 1988a,b; Canfield, 1979; Doisy e ta l., 1976; Linder, 1985; Mertz,
1975, 1979, 1982; Saner, 1979) written about Cr nutrition. Certainly the most
comprehensive review of the Cr literature was by Mertz (1969). Many of the
aspects that were covered in that review will not be covered in the current review.
Some of these topics include the chemistry of Cr, Cr in plants, and Cr analysis
methodology. These topics are important but not the primary focus of the current
body of research. Many of the reviews that have been written segregate human
from animal literature. The present review will include the current pertinent
literature regarding Cr in man and animals. Specifically, this review will
concentrate on the effects of Cr on growth performance, body composition,
metabolism, and immune function.
General
The essentiality of Cr in humans has been well documented. The most
convincing evidence was the dramatic recovery of TPN patients that displayed signs

o f diabetes (Jeejeebhoy et al., 1977). In fact, the suggested safe and adequate daily
intake for Cr is SO to 200 pig, as established by a panel of the United States National
Academy o f Sciences (NAS, 1980). However, the typical diet does not meet the
suggested daily intake (Anderson and Kozlovsky, 1985). Foods that contain higher
concentrations of Cr typically are not eaten in large quantities (e.g., mushrooms,
brewer's yeast, black pepper, prunes, raisins, nuts; Anderson, 1988). Refined foods
have lower amounts of Cr than unrefined foods (Anderson, 1988). Recent evidence
suggests that animal foodstuffs also may not contain adequate Cr to meet the
animals’ requirement (Page et al., 1993).
Growth Performance
The literature regarding the effects of dietary Cr on growth performance of
animals is equivocal. Early work by Schroeder et al. (1963a,b) showed that dietary
Cr improved the growth rate of mice and rats. However, more recent data with
livestock species has yielded variable results. In a publication which contained
multiple experiments, Page et al. (1993) reported increased, decreased, and no
change in growth rate of pigs due to dietary Cr supplementation as chromium
tripicolinate (CrPic). Lindemann et al. (1993) reported that pigs fed marginal lysine
(or crude protein) diets had improved growth performance and feed efficiency in
response to CrPic supplementation; however, pigs fed diets adequate in lysine did
not have improved growth performance when fed CrPic. Other investigators have
reported no effect of dietary Cr supplementation on growth performance of pigs

(Page et al., 1993a; Renteria and Cuardn, 1993), lambs (Kitchalong et al., 1995),
calves (Bunting et al., 1994), or steers (Claeys et al., 1994).
Body Composition
The work that initiated the most recent thrust of Cr research was the finding
by Page et al. (1993b) that dietary Cr supplementation as CrPic (an organic source
o f Cr) dramatically improved body composition of pigs. Specifically,
supplementation of typical com-soybean meal diets with 200 to 400 ppb Cr as CrPic
increased longissimus muscle area and decreased tenth rib fat thickness. These two
carcass traits are of significant economic value to an industry that is trying to
maintain (or gain) market share in an increasingly competitive environment.
Furthermore, the necessity of the organic form of Cr for improved body
composition o f pigs was discovered (Page et al., 1993a,b).
After the initial data of Page et al. (1993b), other investigators have reported
similar improvements in body composition due to dietary Cr supplementation from
organic sources.

Lindemann et al. (1995) reported decreased tenth rib backfat

thickness and increased longissimus muscle area in pigs fed CrPic. Other authors
have reported more subtle differences in body composition. Boleman et al. (1995)
and Mooney and Cromwell (1995) both reported little to no effect of dietary Cr as
CrPic on the linear carcass measurements of pigs. However, carcass dissection and
whole-body composition analysis revealed that dietary Cr increased the rate o f lean

deposition and decreased the rate of fat deposition in pigs. Smith et al. (1994) also
reported decreased backfat thickness of pigs fed Cr nicotinate (CrNic).
Kitchalong et al. (1995) reported that dietary Cr as CrPic supplementation
decreased fat thickness over the tenth rib of lambs. Conversely, Claeys et al. (1994)
reported higher quality grades for steers fed CrNic (thus increased intermuscular fat)
and decreased ribeye area of steers fed 400 ppb Cr as CrCl or 800 ppb Cr as CrNic.
Hasten et al. (1992) reported that female students that were beginning weight
training had increased body weight (BW), primarily due to increased lean body mass
(LBM). However, male students showed no change in BW or body composition
due to Cr supplementation. Evans (1989) reported that male football players had
increased BW, LBM, and calf circumference when they combined dietary Cr
supplementation with weight training. However, Alniada et al. (1995) reported no
beneficial effect of a nutritional supplement that contained Cr as CrPic on males
during resistance training. Other authors have reported increased LBM (Hasten et
al., 1993) and decreased body fat (Hasten et al., 1994, 1995) in rats.
Metabolism
Introduction. The reason for the increased lean and decreased fat in the bodies
o f humans and carcasses of animals given supplemental dietary Cr is not known.
However, Cr is known to be involved in a myriad of steps o f metabolism, including
protein, carbohydrate, and lipid metabolism. Chromium is thought to exert its
effects through the potentiation of insulin action. However, the anabolic nature, and

more specifically, the lipogenic nature of insulin makes the proposed mechanism of
action of Cr more puzzling. The mystery probably is confounded by the fact, that
after decades of research, the cellular mechanism of action of insulin is not well
established.
Erotein. Apart from the multitude of reports from around the world of
increased muscling o f animals and humans given supplemental dietary Cr, little
research has been conducted to determine the cellular or molecular mechanisms
behind this occurrence. Britton et al. (1968) reported that lambs fed molasses or Cr
as CrCl had increased N utilization. This would suggest that changes in lean
composition that have since been reported by other authors also may have occurred;
body composition was not determined in that experiment. Other investigators have
attempted to study the cellular mechanism of action of Cr. Ono et al. (1994)
reported that supplemental dietary Cr for pigs injected with porcine somatotropin
resulted in increased muscle fiber area compared to pigs injected with somatotropin
only. Dietary Cr alone did not affect muscle fiber area. Morris et al. (1994)
reported no effect of dietary Cr supplementation on cardiac growth, protein, or
myofibrillar protein content. Hasten et al. (1995) reported that rat skeletal
myoblasts had increased 3H-leucine uptake, suggesting perhaps an enhancement of
protein synthesis. Rats treated with an intraperitoneal dose of Cr as CrCl had
increased nucleolar and ribosomal RNA synthesis (Okada et al., 1984). However,
the true implications of Cr for protein synthesis are not known.

Lipid. Low serum Cr has been correlated with coronary artery disease in
humans (Newman et al., 1978; Schroeder et al., 1970; Simonoff et al., 1984).
Riales (1979) reported that brewer's yeast (containing Cr) increased HDLcholesterol and decreased LDL-cholesterol without affecting total serum cholesterol.
These findings are consistent with others that have postulated that Cr is responsible
for such effects (Riales and Albrink, 1981; Elwood et al., 1982; Roeback et al.,
1991; Abraham et al., 1992). In fact, Abraham et al. (1980; 1991) reported that Cr
supplementation of rabbits reduced the surface area of aortic plaques that had been
induced by feeding cholesterol.
Press et al. (1990) reported that supplemental CrPic decreased total
cholesterol, LDL-cholesterol, and apolipoprotein B (the principal protein of the LDL
fraction). Supplemental Cr as CrPic also increased apolipoprotein A -l, the principal
protein of the HDL fraction, but did not significantly affect HDL-choIesterol
concentration. However, Hermann et al. (1995) reported that Cr as CrCl was
effective in lowering serum total cholesterol but increased apolipoprotein B in adults
over age fifty. Lefavi et al. (1991) reported that a nicotinic acid-chromium complex
was effective in reducing serum total cholesterol and increasing the total
cholesterol:HDL-cholesterol ratio in male athletes. In addition, Schroeder (1968)
and Schroeder et al. (1971) reported that supplemental Cr reduced serum total
cholesterol in rats and Kitchalong et al. (1995) reported that supplemental Cr
reduced serum cholesterol and NEFA in lambs. In addition, CrPic supplementation

has been reported to decrease serum total cholesterol concentrations in pigs (Page et
al., 1993b), lambs (Kitchalong et al., 1995), and calves (Bunting et al., 1994).
However, Rabinowitz et al. (1983) reported that CrCl, brewer's yeast containing
glucose tolerance factor (GTF), and brewer’s yeast without GTF did not affect
plasma total cholesterol or triglycerides in diabetic men and Amoikon et al. (1995)
reported that CrPic increased serum total cholesterol in pigs. However, it is
possible that changes in the lipoprotein fractions did occur in that study but were not
detected (i.e., they were not measured). Other investigators also have reported a
lack of effect of dietary Cr on lipid measurements in humans (Gondy and Wilson,
1994; Thomas and Gropper, 1995), chickens (Maurice and Jensen, 1978), calves
(Bunting et a)., 1994), and lambs (Kitchalong et al., 1995).
Glucose and Insulin. It is difficult to separate the effect of Cr on glucose and
insulin metabolism. However, the glucose and insulin responses to dietary Cr will
be separated. One of the first defined roles of Cr in mammals was the alleviation of
hyperglycemia in rats (Mertz et al., 1961, 1965, 1969; Schroeder, 1966). The most
striking evidence for the efficacy of Cr in alleviating hyperglycemia is in total
parenteral nutrition (TPN) patients (Jeejeebhoy et al., 1977; Freund et al., 1979).
These patients required insulin injections to lower their blood glucose levels.
However, following the addition of Cr to the TPN solution, the requirement for
insulin was dramatically decreased, if not completely negated. The symptoms of
diabetes also were alleviated. Further evidence of a role for Cr in glucose

10
homeostasis was found for Turner’s syndrome patients. Supplemental Cr was
effective in decreasing hyperglycemia in these patients (Saner et al., 1983).
Other investigators have reported equivocal responses from supplementing the
diets of the elderly with Cr. Offenbacher and Pi-Sunyer (1980) reported that
chromium-rich brewer’s yeast improved glucose tolerance of elderly subjects.
Similarly, Potter et al. (1985) reported that Cr as CrCl was effective in lowering the
plasma glucose response to an oral glucose tolerance test, but plasma insulin levels
were not affected. Bourn et al. (1985) reported that Cr supplementation was
effective in lowering plasma glucose and insulin concentrations in post-menopausal
women. However, Martinez et al. (1985) and Offenbacher et al. (1985) reported
that supplemental Cr did not change glucose tolerance or insulin status in elderly
subjects. Mossop (1983) and Vinson and Bose (1984) reported that diabetic patients
had lower fasting plasma glucose concentrations when they received supplemental
dietary Cr. However, other investigators have found no response to supplemental
Cr in diabetic patients (Sherman et al., 1968; Uusitupa et al.t 1983, 1992). The
reasons for these different results are not clear. Some investigators have suggested
that only those patients with abnormal glucose tolerance will respond to Cr
supplementation. However, previously in the text it was noted that diabetic patients
did not always respond to Cr supplementation. The unknown factors of diabetes and
its associated complications makes it a challenging subject. Glinsmann and Mertz
(1966) reported that diabetic patients responded to Cr supplementation, but patients

with normal glucose tolerance did not. Freiberg et al. (1975) reported that diabetic
or “doubtful11(marginal diabetics) patients had lowered plasma glucose after
supplementation with brewer’s yeast, presumably due to its Cr content. Anderson et
al. (1991), U u et al. (1977, 1978), and Polansky et al. (1991) reported similar
findings comparing patients with normal and abnormal glucose tolerance. Anderson
et al. (1985, 1987) reported that both hypoglycemic and hyperglycemic subjects had
improved glucose status when they received supplemental Cr. However, Evans
(1989) and Levine et al. (1968) reported that some patients with abnormal glucose
tolerance responded to Cr supplementation, but other patients with abnormal glucose
tolerance did not respond to Cr supplementation. The unknown cause(s) of
"responders” and "nonresponders" further complicate the study of Cr nutrition in man
and animals.
The animal data with glucose response to Cr supplementation are just as
variable as the human data. Some investigators have found that supplemental Cr
decreased plasma glucose concentrations, whereas others have reported no effect o f
supplemental Cr on glucose status of animals. Stoecker and Oladut (1985) reported
that Cr supplementation lowered the plasma glucose response 60 min after a glucose
tolerance test in guinea pigs. This may indicate that glucose was cleared from the
plasma at a foster rate; however, clearance rate was not determined. Similarly,
Amoikon et al. (1995) reported that supplemental Cr as CrPic increased the
clearance rate and decreased the half-life of glucose from the plasma of pigs during

an intravenous glucose tolerance test (IVGTT). In a like fashion, Cr as CrPic has
been reported to increase glucose clearance rate in calves (Bunting et al., 1994) and
lower glucose response to IVGTT in lambs (Kitchalong et al., 1995). Evock-Clover
et al. (1993) also reported that supplemental dietary Cr as CrPic was effective in
“normalizing” the plasma glucose levels of pigs injected with porcine somatotropin.
However, other investigators have found no effect o f supplemental Cr on the glucose
tolerance o f steers (Claeys et al., 1994), lambs (Fomea et al., 1994; Sam sell and
Spears, 1989), or hens (Jensen et a l., 1978).
Some investigators have suggested that Cr directly affects the endocrine
pancreas. However, there is a lack o f agreement about the direction of these effects.
Ghafghazi et al. (1980) reported that Cr decreased insulin secretion in isolated
pancreatic islets. However, Strifrier et al. (1993) reported that dietary Cr enhanced
insulin secretion in perfused rat pancreas. Hubner et al. (1989) reported that dietary
C r decreased insulin response to an i.p. glucose tolerance test in gestating rats.
Furthermore, the insulin content o f the entire pancreas o f these dams was decreased,
but the insulin content of the entire pancreas from the neonatal rats (from the Cr
supplemented dams) was increased. It is interesting that these rats supplemented
with C r did not have a change in their glucose tolerance, yet insulin secretion was
obviously affected by Cr.
Some investigators have reported that supplemental dietary Cr differentially
affects insulin binding in tissues. Ward et al. (1994) reported that dietary Cr as
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CrPic decreased insulin binding to plasma membranes of pig liver cells. Berrio et
al. (1995), from the same laboratory, reported that dietary Cr as CrPic increased
insulin binding in isolated pig fat cells and erythrocyte membranes. These data may
indicate that Cr decreases glucose utilization by the liver, and therefore more
glucose is available for uptake by peripheral tissues. However, Steele et al. (1982)
reported that dietary Cr as CrCl did not affect insulin binding in hepatic tissues.
The discrepancy between these findings and those o f Ward et al. (1994) might be
explained by the difference in forms of dietary Cr. Ward et al. (1994) used an
organic source o f Cr (CrPic).
Other investigators have indicated that Cr may act on the enzymes of
gluconeogenesis and glycolysis. Shiau and Chen (1993) reported that supplemental
dietary Cr lowered glucose-6-phosphatase activity in tilapia, but phosphofructokinase
activity was higher in tilapia supplemented with Cr. These same investigators found
that C r supplementation increased weight gain, energy deposition, and liver
glycogen content in fish fed glucose as a carbohydrate source. Campbell et al.
(1989) reported that dietary Cr enhanced liver glycogen synthase activity in
sedentary rats but not in exercise-trained rats.
Stress and Immune Function. Some investigators have postulated that some
type o f "stress” must be imposed before a subject will respond to Cr
supplementation (Anderson, 1994; Waddington, 1994). Indeed, Mertz and Roginski
(1967) found that rats fed a low-Cr, low-protein diet had depressed growth and this

growth depression was alleviated by supplementing the diet with Cr. Subjecting the
rats to exercise or excessive bleeding also improved growth and survivability in
response to supplemental Cr. Exercise, physical trauma, and high sugar intake have
been reported to increase C r losses in man (Anderson, 1982, 1988, 1989). Other
investigators also have shown a negative correlation between plasma Cr and plasma
glucose levels (Morris et al., 1988a,b).
The relationship between Cr status and glucose utilization may be further
strained by physiological stress. Pekarek et al. (1975) reported that acute infection
with sandfly fever dramatically decreased serum Cr levels and glucose disappearance
rates in humans. Investigators in the animal sciences also have indicated that
supplemental C r may be beneficial in the presence o f stressors. Chang and Mowat
(1992) reported that transport-stressed feeder calves had reduced serum cortisol
when they were provided supplemental dietary Cr. In addition, supplemental dietary
C r increased serum immunoglobulin M and total immunoglobulins in calves fed
diets with soybean meal but had no effect in calves fed urea-com supplementation.
Mowat et al. (1993) and Wright et al. (1993) reported that dietary Cr decreased
morbidity in transport-stressed feeder calves. The improvements in gain and
morbidity have been linked to immune status o f these animals. Moonsie-Shageer
and Mowat (1993) reported that supplemental dietary C r decreased morbidity and
increased antibody titers and immunoglobulin Gj in stressed feeder calves.
Supplemental Cr also increased indicators of cell-mediated immunity in

periparturient dairy cows and in dairy cows during early lactation (Burton et a l.,
1993). Other investigators have noted positive effects of Cr supplementation on
immune status of calves (Chang et al., 1994; Lindell et al., 1994; Wright ct al. ,
1994) and pigs (van Heugten and Spears, 1994).

CHAPTER n i
EFFECT OF DIETARY CHROMIUM SOURCE ON GROWTH, CARCASS
CHARACTERISTICS, TISSUE CHROMIUM CONCENTRATIONS, AND
PLASMA METABOLITE AND HORMONE CONCENTRATIONS IN
GROWING-FINISHING PIGS

Introduction
Page et al. (1993a) reported no effect of Cr chloride hcxahydrate (CrCl) on
body composition or metabolites in pigs; however, Cr tripicolinate (CrPic) was
reported to decrease tenth rib backfat thickness and increase longissimus muscle area
(Page et a l., 1993a,b). Other authors have also reported improvements in body
composition o f swine from supplemental dietary CrPic (Renteria and CuanSn, 1993;
Mooney and Cromwell, 1994; Boleman et a l., 1995; Lindemann et a l., 1995;
Mooney and Cromwell, 1995). At least one possible reason for Ihe difference in
response to supplemental dietary Cr may be the form of Cr. The chemical
composition o f Cr compounds has been reported to affect the biological activity of
these compounds (Evans and Pouchnik, 1993). Page et al. (1993b) reported no
effect o f CrCl, picolinic ad d , or the combination o f CrCl and picolinic add on body
composition o f pigs. However, the chemical complex o f Cr and picolinic acid in
CrPic increased the proportion o f muscle and decreased the proportion of fat in pigs
(Page et a l., 1993a,b). Thus it appeals that the complex o f Cr and picolinic acid (or
perhaps some other organic molecule) is necessary for Cr to elicit beneficial effects
on carcass composition o f pigs. Therefore, the objective o f this experiment was to
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determine the effects o f different Cr sources (inorganic and organic complexes) on
growth, carcass characteristics, metabolite and hormone concentrations, and tissue
mineral concentrations in growing-finishing pigs.

Materials and Methods
Animals and Dietary Treatments

Crossbred (Yorkshire x Hampshire x Duroc) pigs were used [avg. initial body
weight (BVV)=18.1 kg]. The pigs were allotted to treatment on the basis of BW in
a randomized complete block design; ancestry was equalized across treatments.
Each treatment was replicated four times with four pigs per replicate pen. There
were four pens o f four pigs each which were fed a control diet (no Cr
supplementation). Sex (two gilts and two barrows) was equalized within pen.
The pigs were fed a com-soybean meal basal diet (Table 3.1) formulated to
provide 120% o f the (NRC, 1988) lysine requirement during both the grower and
finisher phases o f production. The dietary treatments consisted o f an
unsupplemented control diet (Basal) and the Basal diet supplemented with 200 n z
Cr/kg diet as either chromium chloride hexahydrate (CrCl; Sigma Chemical Co.,
St.Louis, MO), Cr acetate (CrAc), Cr oxalate (CrOx), Cr nicotinate (CrNic), Cr
tripicolinate (CrPic-1; USDA source), Cr nicotinate-glycine-cysteine-glutainate
complex (CrNGCG), or Cr tripicolinate (CrPic-2; commercial source, Nutrition

18
Table 3.1. Composition o f the basal diets, as-fed basis
Item

Grower

Finisher
%

Com

73.28

80.38

Soybean meal, 44% CP

24.72

17.90

Defluorinated rock phosphate

.75

.33

Oyster shell flour

.70

.84

Salt

.25

.25

Vitamin premix*

.25

.25

Trace mineral premix”

.05

.05

‘Provided the following per kilogram of diet: riboflavin, 4.4 mg; dpantothenic acid, 22 mg; niacin, 22 mg; vitamin B12, 22 /ig; d-biolin, 220 /ig;
choline chloride, 440 mg; vitamin A, 4400IU; vitamin D3, 4 4 0 1U; vitamin £ ,1 1
1U; menadione dimethylpyrimidinol bisulfite, .25 mg; S e ,. 1 mg.
’’Provided the following per kilogram o f diet: Zn, 75 mg; Fe, 87.5 ntg; Mil,
30 mg; Cu, 8.75 mg; I, 1 mg; Ca, 9 mg.

21, San Diego, CA). Chromium acetate, CrOx, CrNic, CrPic-1, and CrNGCG were
supplied by Dr. Richard Anderson, Nutrient Requirements and Function Laboratory,
USDA, Beltsville, MD. These particular compounds were chosen based on the
ability to obtain them, the use of some o f them in previous research (CrPic, CrNic,
and CrCl), and the need to evaluate additional organic compounds. The pigs were
allowed to consume the treatment diets on an ad libitum basis. During the grower
phase o f production the pigs were penned in 1.8-m x 2.4-m pens in an enclosed
facility with totally slatted floors. During the finisher phase o f production the pigs
were penned in l.S-m x 2.9-m pens in a curtain-sided facility with totally slatted
floors. Pigs were switched to finisher diets when the average BW of a block was
approximately S3 kg. This experiment was conducted from January through April
of 1988.
Blood Sampling
All pigs were bled via the anterior vena cava following 20 h without access to
feed and then again at 2 h postfeeding on days 21 and 77 o f the experiment. Blood
for serum glucose and nonesterified fatty acid (NEFA) analysis was placed into
tubes containing IS mg sodium fluoride, whereas blood for other serum metabolite
and hormone analyses was placed into tubes without the glycolytic inhibitor. The
blood samples were centrifuged for 20 min at 1,600 X g at 4°C . Serum was
collected and frozen (-20 °C) for later analyses.
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Carcass Traits
Pigs were removed from the experiment when their BW was approximately
100 kg (actual final average BW = 98.1 kg). Pigs were killed via stunning
(electrical or captive bolt) followed by exsanguination at the Louisiana State
University Agricultural Center Animal Science Department Meats Laboratory or a
commercial facility. Hot carcass weights were taken with heads on the carcass and
leaf fat in the carcass. Longissimus muscle area (LMA) at the tenth .rib interface
and tenth rib fat (TRF) thickness three-fourths the distance from the midline were
measured after approximately 20 h at 2°C. Longissimus muscle area and TRF were
adjusted to 104.3 kg (National Swine Improvement Federation, 1987), and
percentage o f muscling (PM) was calculated by methods described by the National
Pork Producers Council (1991).
Tissue samples were collected from common sections o f the liver, kidney,
pancreas, and heart o f two pigs from two replicate pens (four replicate pens for CrCl
and CrPic-2 treatments) at the time o f slaughter for tissue Cr, Zn, Cu, and Fe
analyses. In addition, the tenth rib portion o f the longissimus muscle was removed
from the same pigs for C r, Zn, Cu, and Fe analyses.
Chemical^Analyses
Serum was analyzed for glucose (Sigma Chemical Co, 1990) and NEFA
(NEFA-C Kit, ACS-ACOD Method; Wako Chemicals USA, Inc., Richmond, VA)
concentrations using spectrophotometric procedures outlined in commercially-
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available kits. Serum was analyzed for total cholesterol, urea N, and triacylglycerol
concentrations by automated “centrifichem" procedures (conducted by USDA
personnel, Nutrient Requirements and Function Laboratory, Beltsville, MD). Tissue
mineral analysis was conducted according to the procedure of Hill et al. (1986)
(conducted by USDA personnel, Nutrient Requirements and Function Laboratory,
Beltsville, MD).
Serum insulin was assayed by the RIA method o f Amoikon et al. (1995).
Guinea pig anti-bovine insulin antiserum (Code No. 65-101, Lot No. GP616; ICN
ImmunoBiologicals, Lisle, IL) was used at a 1:60,000 final dilution. Purified
porcine insulin (26.1 /tU/ng; Sigma Chemical Co.) and bovine ,2SI-insulin (ICN
Biomedicals, Inc., Costa Mesa, CA) were used as the standard and radioligand,
respectively. Sheep anti-guinea pig antiserum produced in our laboratory was used
at a 1:4 dilution as the precipitating antibody. The intraassay CV for the insulin
RIA as determined by a pooled bovine plasma sample was 7.7% .
Serum GH was measured by a double-antibody RIA technique based on
antiserum (AFP-10318545; A.F. Parlow, Pituitary Hormone and Antisera Center,
Harbor-UCLA Medical Center, Torrance, CA) against porcine GH (pGH). Highly
purified pGH was radioiodinated via the chloramine-T method (Greenwood et al.,
1963; 2.5 ng o f chloramine-T//ig o f GH, 0 °C for 30 sec). The antiserum was
diluted 1:150,000 in PBS containing .033 M EDTA, .112% normal rhesus monkey
serum (Calbiochem, San Diego, CA), and 33% noninhibitory horse serum; 300 piL
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o f this solution was used per tube. The horse serum was added to minimize and to
stabilize nonspecific binding of radioiodinated pGH to the assay tubes. Antiserum
(Calbiochem) against rhesus monkey immunoglobulin-G was diluted 1:21 and was
used at 200 pL per tube to precipitate the primary antibody. Cross-reactivities of
other porcine pituitary hormones in the assay were as follows (percentage relative to
pGH): prolactin, .08; FSH, .12; LH, .001; and thyroid-stimulating hormone, .004
(A .F. Parlow, personal communication). Inhibition curves produced by serial
dilutions of porcine sera and pituitary extracts were parallel to those produced by the
reference standard (USDA-pGH-Bl; National Hormone and Pituitary Agency,
Baltimore, MD). Sensitivity of the assay averaged . 1 ng; the sample size was 200
(iL in a typical assay. Intra- and interassay CV in the GH RIA were 9.6 and 9.8% ,

respectively.
Statistical Analyses
Data from these experiments were analyzed by ANOVA (Steel and Torrie,
1980) using the general linear model (GLM) procedure o f SAS (198S). The data
were analyzed as a randomized complete block design with initial BW as the
blocking factor. The pen o f pigs was the experimental unit for all data. Statistical
analysis o f dressing percentage included final BW in the model as a covariate. Data
are presented as means with LSD means separation procedures to indicate treatment
differences at P < .05, unless otherwise indicated. In addition, a single degree-of-
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freedom contrast was done to compare the main effect of Cr supplementation (i.e.,
the basal diet vs all Cr diets).

Results
Growth Performance
During the grower phase o f production, average daily gain (ADG) was
reduced (P < .01) in pigs fed Cr (basal diet vs all Cr diets, Table 3.2). Average
daily gain was reduced (P < .05) in pigs fed CrCl, CrAc, or CrOx compared with
the pigs fed the basal diet (Table 3.2). Chromium supplementation as CrNic, CrPic1, CrNGCG, or CrPic-2 resulted in intermediate ADG. The decreased ADG did not
result (P > .05) from differences in feed intake, although there was a tendency
(P < . 12) for Cr to decrease feed intake; therefore, differences in feed efficiency
were observed. Pigs fed CrCl were less efficient (P < .05) than pigs ted CrAc,
CrOx, CrNic, CrPic-1, or CrPic-2. However, pigs fed the basal diet or CrNGCG
had intermediate gain:feed.
During the finisher phase o f production the main effect of Cr was opposite of
that observed during the grower phase. Pigs fed diets containing Cr tended to eat
more feed (P < . 17) and gain more weight (P < . 10). Average daily gain was
lower (P < .05) for pigs fed CrOx than for pigs fed CrPic-2; pigs fed the other
dietary treatments had intermediate (P > .05) ADG. The response to supplemental
C r was more variable during the finisher phase compared with the grower phase.
Pigs fed CrCl had greater (P < .05) average daily feed intake (ADFI) than pigs fed
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the basal diet or CrAc, CrOx, or CrPic-1. Pigs fed CrPic-1, CrPic-2, and CrNGCG
had greater (P < .05) ADFI than pigs fed CrAc or CrOx.
During the overall combined grower and finisher phases there was no main
effect o f Cr (P > .20). Average daily gain of pigs fed CrOx was lower than ADG
of pigs fed CrNic, CrNGCG, or CrPic-2. Pigs fed the basal diet or CrCl, CrAc, or
CrPic-1 had intermediate ADG. Pigs fed CrCl or CrNGCG had greater ( P < .05)
ADFI than pigs fed CrAc, CrOx, or CrPic-1. Pigs fed the basal diet, CrNic, or
CrPic-2 had intermediate ADFI. Feed efficiency was less (P < .05) in pigs fed
CrCl compared with pigs fed CrAc, CjO x, CrNic, CrPic-1, or CrPic-2. Pigs fed
the basal diet or CrNGCG had intermediate feed efficiency.
f a m iM T raits

Longissimus muscle area, TRF, and PM were not affected (P > .05) by
dietary treatment (Table 3.2). Dressing percentage was less (P < .05) in pigs fed
CrAc or CrOx compared with pigs fed CrCl. Pigs fed the basal diet, CrNic, CrPic,
or CrNGCG had intermediate DP. There was no (P > .20) main effect of Cr
supplementation on carcass traits.
S em m M fttahnlitea and H orm ones

Day 21. In pigs that had not had access to feed for 20 h, serum glucose was
lower (P < .05) in pigs fed C r (main effect). Serum glucose was lower (P < .05)
in pigs fed CrNic, CrNGCG, or CrPic-2 than in pigs fed the basal diet; pigs fed
other Cr sources had intermediate serum glucose concentrations (Table 3.3). Serum

Finisher phase
ADG, kg
ADFI, kg
Gain/feed

.82*
3.10*
.263

.89*
3.49"
.256

Overall
ADG, kg
ADFI, kg
Gain/feed

.81*
2.69**
.301*

.79*
2.87b
.276*

*
00
°sr

Table 3.2. Effect o f dietary chromium source on growth performance and carcass characteristics of growing-finishing pigs*
Chromium source
___________________________________ Pooled
Criterion
Nicotinate
SEM
Oxalate
Complex
CrPic-2
Basal
Chloride Acetate
CrPic-1
Grower phase
ADG, kg
.74°*
.71*
.77*
.02
.70*
.76**
.77*
.81b
.75**
2.34
ADFI, kg
2.02
.12
2.03
2.16
2.11
2.31
2.06
2.28
.348*
.340*
Gain/feed
.307
.354b
.354b
.366"
.365"
.368b
.015

3.09*
.284

.81c
2.89*
.280

.89*
3.29**
.272

.81*
2.53*
.319*

.76*
2.44*
.311b

.82b
2.69**
.3Q5b

.88*
3.18**
.277
.81*
.261**
.312”

.90*
3.40*
.265

.91"
3.39*
.270

.03
.09
.011

.84"
2.84"
.295*

.84"
2.73*
.307"

.02
.07
.009

Carcass characteristics
LMA, cm2
30.4
31.2
29.3
29.9
29.4
29.9
.8
29.6
30.1
3.2
.1
TRF, cm
2.9
3.1
2.9
3.0
3.0
2.9
2.9
.7
PM, %
46.8
44.6
45.9
44.7
45.5
45.2
45.9
46.0
.4
80.2*
80.7*
DP, %
80.3*
80.5*
80.9*
81.1*
81.3b
80.2*
'Data are means of four replicates of four pigs per replicate; average initial BW = 18.1 kg. The pigs were fed a com-soybean
meal diet without (Basal) or with 200 ftg Cr/kg diet as Cr chloride, Cr acetate, Cr oxalate, Cr nicotinate, Cr tripicolinate
(CrPic-1 ;USDA synthesized), Cr nicotmate-glycine-cysteine-glutamate complex, or Cr tripicolinate (CrPic-2; Commercial source);
LMA=longissimus muscle area, TRF=tenth rib fat thickness, PM=percentage of muscling, DP=dressing percentage.
**Means in the same row with uncommon superscripts differ. P < .05.
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glucose was not different (P > .05) between treatments in samples collected 2 h
postfeeding. Serum NEFA levels were not different (P > .05) between treatments
for pigs that had not had access to feed for 20 h. However, 2-h postfeeding serum
NEFA levels were lower (P < .05) in pigs fed CrPic-1 than pigs fed CrCl. Other
treatment diets resulted in intermediate serum NEFA levels. Serum cholesterol was
not affected (P > .05) by dietary treatment in pigs that had not had access to feed
for 20 h (Table 3.4). However, 2 h postfeeding serum cholesterol was less
(P < .05) in pigs fed CrNGCG than in pigs fed CrCl, CrAc, or CrPic-1; other
treatments resulted in intermediate cholesterol concentrations. Seium biacylglycerol
concentrations for pigs that had not had access to feed for 20 h were lower
(P < .05) in pigs fed CrNic, CrNGCG, or CrPic-2 than pigs fed CrOx; pigs fed
other dietary treatments had intermediate serum triacylglycerol concentrations.
Serum urea N, insulin, and GH concentrations were not different (P > .05) between
dietary treatments for both the 20 h without access to feed and 2 h postfeeding
samples. In addition, there was no main effect o f C r (P > . 10) on any serum
metabolite (except glucose) or hormone on Day 21.
Day 77. In pigs that had not had access to feed for 20 h, serum NEFA
concentrations were lower (P < .09) in pigs fed Cr (main effect). Serum NEFA
concentrations were lower (P < .05) in pigs fed CrPic-2 than pigs fed the basal diet
(Table 3.3). All other dietary treatments resulted in intermediate NEFA
concentrations. For the 2 h postfeeding blood samples, serum NEFA concentrations
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Table 3.3. Effect o f dietary chromium source on serum glucose, NEFA, insulin, and growth hormone concentrations in growingfinishing pigs*_____________________________________________________________________________________________
Chromium source
Pooled
Criterion___________ Basal
Chloride Acetate
Oxalate
Nicotinate
CrPic-1
Complex
CrPic-2
SEM
Glucose, mmol/L
Day 21
Unfed
Fed
Day 77
Unfed
Fed
NEFA, mEq/L
Day 21
Unfed
Fed
Day 77
Unfed
Fed
table con’d)

4.4b
9.7

4.2**
9.5

4.3*
10.5

4.3*
10.8

4.0®
11.3

4.1*
11.2

4.0®
10.7

4.0®
9.8

.1
.8

4.1
6.0

4.2
5.6

4.2
5.6

4.3
5.6

4.3
5.7

4.1
5.9

4.1
5.7

4.3
5.7

.2
.4

1.050
.173*

.944
.170*

.883
.194*

.986
.199*

1.060
.183*

1.036
.160b

1.034
.165*

.984
.167*

.065
.013

.669b
.159*

.521*
.246”

.441*
.163*

.625*
.172*

.459*
.144®

.581*
.220*

.539*
.146®

.433®
.245b

.080
.032

S3

I

Insulin, pU/mL
Day 21
Unfed
Fed
Day 77
Unfed
Fed

.49
64.0

.56
53.1

.28
43.6

.60
52.6

.10
56.0

.28
61.7

.31
58.7

.16
52.4

.20
9.7

1.93*
32.7

1.84e
33.4

2.34*
25.9

2.05*
27.7

2.10*
44.1

2.66*
44.8

3.01*
39.2

4.20*
27.6

.77
9.2

Growth hormone, ng/tnL
Day 21
5.2
Unfed
3.5
6.6
4.3
4.5
4.4
5.0
4.6
1.1
Fed
4.7
4.5
4.7
4.4
4.4
3.8
3.8
3.8
.8
Day 77
Unfed
1.5
1.2
2.4
1.0
.7
1.9
1.1
.6
.6
Fed
1.2
2.3
2.3
2.2
1.5
2.5
2.6
.7
1.6
’Data are means of four replicates with four pigs per replicate; average initial BW = 18.11$. The pigs were fed a com-soybean
meal diet without (Basal) or with 200 pg Cr/kg diet as Cr chloride, Cr acetate, Cr oxalate, Cr nicotinate, Cr tripicolinate
(CrPic-l;USDA synthesized), Cr nicotinate-glycine-cysteine-glutamate complex, or Cr tripicolinate (CrPic-2; Commercial source).
b,cMeans in the same row with uncommon superscripts differ, P < .05.
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Table 3.4. Effect o f dietary chromium source on serum urea nitrogen, cholesterol, and triacylglycerol concentrations of growingfinishing pigs*_______________________________________ _____________________________________________________
Chromium source
Pooled
Criterion
Basal
SEM
Nicotinate
Complex
Chloride Acetate
Oxalate
CrPic-1
CrPic-2
Urea nitrogen, mmol/L
Day 21
Unfed
10.6
10.4
9.7
9.8
10.0
9.1
9.5
10.0
.5
9.4
Fed
9.8
9.9
9.8
9.9
9.8
9.8
9.9
.5
Day 77
10.0*
Unfed
8.6*
9.6*
1.0
* 11.6*
8.8*
8.9*
8.9*
7.6s
12.4
Fed
10.3
10.1
10.1
1.2
10.0
10.6
8.9
10.8
Cholesterol, mmol/L
Day 21
Unfed
Fed
Day 77
Unfed
Fed

2.8
2.9*“

2.9

2.9
3.1*

2.9
2.9*

2.7
2.8*

2.9
3.0*

2.7
2.7*

2.8
2.9*

.1
.1

2.5*
2.7

2.5*
2.7

2.7*
2.6

2.4*
2.6

2.5*
2.5

2.6*
2.7

2.5*
2.6

2.6*
2.7

**

99.8*
53.6

102.5*
71.4

139.5*
59.3

82.8*
66.2

103.2*
72.1

90.0*
53.5

91.8*
63.7

15.1
8.0

36.6
32.4

38.3
27.8

39.5
31.6

32.8
24.6

37.8
30.9

38.7
31.7

27.9
24.3

4.7
2.9

Triacylglycerol, mg/dL
Day 21
Unfed
98.6
Fed
59.1
Day 77
Unfed
29.3
Fed
28.6
(table con’d)

.1

D ata are means of four replicates with four pigs per replicate; average initial BW = 18.1 kg. The pigs were fed a com-soybean
meal diet without (Basal) or with 200 pg Cr/kg diet as Cr chloride, Cr acetate, Cr oxalate, Cr nicotinate, Cr tripicolinate
(CrPic-1;USDA synthesized), Cr nicotinate-glycine-cysteine-glutamate complex, or Cr tripicolinate (CrPic-2; Commercial source).
*,cMeans in the same row with uncommon superscripts differ, P < .05.
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were lower (P < .05) in pigs fed CrNic or CrNGCG than in pigs fed CiCJ or
CrPic-2 forms; other dietary treatments resulted in intermediate NEFA
concentrations. In pigs that had not had access to feed for 20 h, serum insulin
concentrations were greater (P < .05) in pigs fed CrPic-2 than in pigs fed CrCl;
other dietary treatments resulted in intermediate serum insulin concentrations. In
pigs that had not had access to feed for 20 h, pigs fed CrPic-2 had lower serum urea
N concentrations than in pigs fed CrCl. All other dietary treatments resulted in
intermediate serum urea N concentrations for the 20 h without access to feed and no
differences (P > .05) were observed between treatments for the 2 h postfeeding
samples. In pigs that had not had access to feed for 20 h, plasma cholesterol was
lower (P < .05) in pigs fed CrOx than in pigs fed CrAc. In the 2 h postfeeding
samples, no differences (P > .05) between treatments were observed. Serum
glucose, GH, and triacylglycerol concentrations were not affected (P > .05) by
dietary treatments in either the 20 h without access to feed or 2 h postfeeding
samples. There was no main effect of Cr (P > . 10) on any serum metabolite
(except NEFA) or hormone on Day 77.
Tissue Minerals
Chromium. Chromium supplementation (basal diet vs all Cr diets) increased
heart (P < .10), kidney (P < .11), liver (P < .03), and pancreas (P < .09) Cr
concentrations but not (P > . 10) longissimus muscle Cr concentration (Table 3.5).
Heart Cr concentration was greater (P < . 10) in pigs fed CrOx compared with pigs

Table 3.5. Effect of dietary chromium source on tissue chromium, copper, zinc, and iron concentrations of pigs*
Chromium source____________________________________
Criterion
Complex
CrPic-2
Basal
Oxalate
Nicotinate
Chloride Acetate
CrPic-1
Chromium, ng/g dry tissue
Heart
8.4®
9.2*
18.7**
19.8*
21.9"
16.3**
11.8*®
Kidney
9.7*
10.4*
42.2**
77.7b
37.8*
50.4*
35.3*
14.9*
Liver
13.2*
17.1*
'34/3*
20.4®
9.3*
19.2*
8.6*
35.0>
4.1®*
3.7®*
Pancreas
2.6*
1.8®
12.2*
17.6®
29.6b
8.3®*
6.4
4.1
6.8
Longissimus muscle 2.2
2.6
2.5
4.8
5.0
Copper, A^g/g dry tissue
Heart
20.1*
Kidney
19.9
Liver
25.6
Pancreas
4.5*
Longissimus muscle 1.8
Zinc, /^g/g dry tissue
Heart
Kidney
Liver
Pancreas
Longissimus muscle
(table con’d)

86.0*
102.5
271.4b
133.3b
44.0*

Pooled
SEB
3.7
14.4
4.1
3.7
2.1

19.6^
19.7
21.2
4.8*
1.8

20.2*
20.6
22.4
4.6*
1.7

19.8*
20.6
21.0
4.9b
2.0

20.4b
19.9
24.6
3.9®
1.8

19.7*
23.6
21.6
4.4*
1.9

19.8*
19.5
22.0
4.3*
1.7

19.1®
18.3
20.5
4.4*
2.1

.5
2.0
2.0
.4
.2

89.2*
100.8
225.3*
129.9b
44.4*

85.2®
103,9
266.8*
146.3*
49.4b

87.2*
102.2
241.8*
130.2*
46.3*

92.4b
99.7
210.7*
82.7®
48.1*

90.0*
109.2
236.6*
138.6®
47.1*

84.5®
102.6
205.0*
105.3*
47.3*

83.9®
93.9
190.8®
110.8*
42.6®

2.6
8.2
29.8
17.8
2.4

Iron, £tg/g dry tissue
Heart
199.0"*
199.4"*
208.2"*
205.0“
206.8"*
7.2
193.5*
212.3"*
215.8"
Kidney
171.3d
180.7®"
200.31*
210.8"
172.8"
181.8*"
171.9"
206.8"*
9.9
Liver
654.9bed
721.7*“
601.8W
556.8®"
781.0*
775.3"
668.1"®"
516.2"
73.8
Pancreas
39.1“
38.9"®
47.7"*
47.6“
42.4"*
51.5"
35.6*
48.1"
5.6
Longissimus muscle 14.8
14.7
14.4
16.0
14.9
14.8
15.4
13.0
1.5
D ata are means of four (CrCl and CrPic-2) or two oreplicates (all other sources) with two pigs per replicate; average initial BW =
18. i kg. The pigs were fed a com-soybean meal diet without (Basal) or with 200 fig Cr/kg diet as Cr chloride, Cr acetate, Cr
oxalate, Cr nioodnate, Cr tripicolinate (CrPic-l;USDA synthesized), Cr nicotinate-glycine-cysteine-glutamate complex, or Cr
tripicolinate (CrPic-2; Commercial source).
MA*Meant in the same row with uncommon superscripts differ, P < .10.
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fed the basal diet* CrNic, or CrPic-2. Kidney Cr concentration was greater (P <
. 10) in pigs fed CrAc than in pigs fed the basal diet, CrCl, CrNic, CrPic-1, or
CrNGCG. liv e r Cr concentration was not different (P > .10) between the pigs fed
CrAc or CrOx and both o f these forms o f Cr resulted in greater (P < , 10) liver Cr
concentration than in pigs fed the basal diet or the other Cr sources. Pancreas Cr
concentration was greater (P < . 10) in pigs fed CrCl than in pigs fed the other Cr
sources. Longissimus muscle Cr concentration was not affected (P > . 10) by dietary
treatment.
Copper. Overall Cr supplementation (basal diet vs all Cr diets) did not affect
(P > .10) tissue copper concentrations. Heart copper concentrations were greater
(P < . 10) in pigs fed CrNic than in pigs fed CrPic-2. Pancreas copper
concentration was greater (P < .10) in pigs fed CrOx than in pigs fed CrNic.
Kidney, liver, and longissimus muscle copper concentrations were not affected
(P > . 10) by dietary treatment.
Zinc. Chromium supplementation (basal diet vs all Cr diets) did not affect
(P > . 10) heart, kidney, liver, pancreas, or longissimus muscle zinc concentrations.
Heart zinc concentration was greater (P < . 10) in pigs fed CrNic than in pigs fed
CrAc, CrNGCG, or CrPic-2. liv e r zinc was lower (P < .10) in pigs fed CrNic or
CrPic-2 than in pigs fed CrAc, CrNGCG, or CrPic-2. Longissimus muscle zinc
concentration was greater (P < .10) in pigs fed CrAc than in pigs fed CrPic-2.
Pancreas zinc concentration was lower (P < . 10) in pigs fed CrNic than in pigs fed
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the basal diet, CrCl, CrAc, or CrPic-1. Kidney zinc concentration was not different
(P > . 10) among dietary treatments.
. Icon. Heart iron concentration was greater (P < . 10) in pigs fed CrPic-2 than
in pigs fed CrPic-1. Kidney iron concentration was greater (P < . 10) in pigs fed
CrCl, CrNic, or CrPic-2 than in pigs fed the basal diet, CrAc, or CrNGCG. liv e r
iron concentration was greater (P < .10) in pigs fed CrAc or CrNic than in pigs fed
CrOx or CrNGCG. Pancreas iron concentration was greater (P < .10) in pigs fed
CrNic or CrPic-2 than in pigs fed CrNGCG. Longissimus muscle iron
concentration was not affected (P > .10) by dietary treatments. In addition, there
was no main effect o f Cr (P > .10; basal diet vs all Cr diets) on tissue iron
concentrations.
Discussion
G row th Perfnmiflncp.

In general the supplementation o f diets for pigs with various Cr sources had
minimal effects on gain, feed intake, and gain:feed. For example, in the grower
phase, the decrease in growth due to CrCl, CrAc, and CrOx was overcome in the
finisher phase (with the exception o f CrCl). It appeared that the overall decrease in
growth (the basal diet vs all C r sources) during the grower phase traded to be
compensated for during the finisher phase.
The effect o f different Cr sources on growth performance of animals
(especially domestic livestock) has not been evaluated to any extent. Most studies
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have evaluated either CrCl or CrPic. For example, Page et al. (1993b) investigated
either increasing dietary concentrations o f CrPic or individual additions o f CrCl,
picolinic acid, or the combination of CrCl and picolinic acid. In one experiment,
CrPic decreased ADG and ADFI in a dose dependent manner from 0 to 800 ppb o f
dietary Cr as CrPic (Page et al., 1993b). In another experiment ADG was
decreased in a cubic manner, although the decrease was primarily at one dietary
concentration o f Cr (100 ppb as CrPic). A third experiment found no effect on
growth performance o f pigs fed singular additions of either CrCl or picolinic acid or
the combination of CrCl and picolinic acid. Lindcmann et al. (1995) reported that
250 and 500 ppb C r as CrPic tended to reduce ADFI without affecting ADG,
resulting in an increase in gain:feed. However, Evock-Clover et al. (1993) repoited
no effect o f 300 ppb C r as CrPic on ADG, ADFI, or gainrfeed. Other authors have
reported either decreased (Boleman et a l., 1995) or increased (tendency vs CrCl,
P < . 11; Mooney and Cromwell, 1994) growth of pigs due to dietary CrPic
supplementation. Smith et al. (1994) reported no effect of 200 ppb Cr from CrNic
on gain, feed intake, or gain:feed.
The conditions under which Cr supplementation results in changes in growth
performance have not been defined. Some investigators have suggested that "stress”
is necessary to induce a response to supplemental Cr (Anderson, 1994; Mowat,
1994). We believe that the pigs in the current investigation experienced minimal
production stress. The pigs were housed in a new facility during the finisher phase
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and were allowed pen space well in excess o f that required (Whittemore, 1993).
Other experiments from this institution (Page et al.( 1993b) were conducted in older
facilities, which may have been more stressful to the pig. This may explain the
difference in results obtained from dietary C r supplementation.
Ca rrass Traits

The lack o f an effect o f supplemental Cr (especially CrPic) on carcass traits in
this investigation is hard to explain. Many investigators have reported
improvements in carcass traits o f pigs fed Cr (Page et al., 1993a, b; Renteria and
Cuarrin, 1993; Smith et al., 1994; Lindemann et al., 1995). However, not all
reports have been positive regarding the effect o f supplemental Cr on linear carcass
measurements. Boleman et al. (1995) reported that supplemental CrPic increased
TRF when it was fed during the growing and finishing phases but decreased TRF
when it was fed only during the finishing phase. Mooney and Cromwell (1994)
reported no effect of dietary C r as CrCl or CrPic on TRF but an increase in LMA
due to either CrCl or CrPic supplementation. However, Page et al. (1993a)
reported no effect o f CrCl on carcass measurements. Boleman et al. (1995) and
Mooney and Cromwell (1995) both reported that pigs fed supplemental CrPic did
not have measurable differences in linear carcass measurements (i.e., LMA and
TRF). However, carcass dissection and chemical analysis revealed that pigs fed
CrPic had increased carcass lean and decreased carcass fat compared with
unsupplemented controls. Other investigators also have reported variable responses
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to dietary Cr supplementation of swine diets. Lindemann et al. (1995) reported no
effect o f CrPic on carcass traits in one experiment and increased LMA and
decreased TRF in another experiment. Evock-Clover et al. (1993) reported no
effect o f dietary CrPic on carcass measurements in pigs with or without exogenous
pituitary porcine somatotropin (ppST) administration. Some investigators have
postulated that the genetic potential for lean growth may influence the response
obtained in pig carcass composition (Roger Campbell, Prince Nutrition Conference,
1993). Pigs with increased potential for lean gain, and thereby less fat, may not be
as responsive to dietary Cr supplementation. The genotype used in this experiment
is considerably different than the genotype first used by Page et al. (1993b) at this
institution. The genetic potential for lean gain of the pigs from the Louisiana State
University Agricultural Center Swine Unit has continually increased over the years
and thus may be affecting the responses we are able to obtain in pig carcass
composition. In addition, as noted previously, this study was conducted in a new
finishing facility. If stress was responsible for the response to Cr supplementation in
previous studies, then perhaps these new facilities reduced the amount o f stress to
which these pigs were exposed. Another proposed reason for a lack o f response to
Cr is that over time we may have contaminated our feed mixing equipment at the
Louisiana State University Agricultural Center Swine Unit. We do not have
evidence to support this hypothesis; the diets have not been analyzed for C r content.
More importantly, some researchers believe that as Cr stores of a population (i.e., a
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herd) are repleted (assuming they were depleted initially) then it may not be possible
to demonstrate a response to supplemental Cr (Merlin Lindemann, personal
communication). This hypothesis is in line with the belief that Cr is acting as an
essential nutrient and not as a pharmacological agent.
Serum Mfttnhnlites and Hormones

After 21 days on the treatments CrNic, CrNGCG, and CrPic-2 reduced serum
glucose. In fact there was a main effect of Cr in reducing serum glucose (the basal
diet vs all Cr sources). However, none of the Cr sources affected serum glucose
after 77 days on the experimental diets. Most reports o f reduced serum glucose
levels have been in the early stage o f Cr supplementation. For example, Kitchalong
et al. (1995) reported a reduced response to an IVGTT for sheep fed CrPic during
the first 2 wk of an experiment but lack o f a response after 10 wk of
supplementation. Other investigators have reported increased glucose clearance
rates due to CrPic supplementation (Bunting et al., 1994; Amoikon et al., 1995) in
relatively short-term experiments. Page et al. (1993b) reported no difference in
serum glucose o f pigs from a single blood sample taken 3 h after initiation of
feeding after 73 d of CrPic supplementation. However, Evock-Clover et al. (1993)
reported that CrPic supplementation “normalized" plasma glucose concentrations in
pigs injected with ppST in an experiment o f relatively shorter duration (39 to 50 d).
Lindemann et al. (1995) reported a decrease in the insulin:glucose ratio o f sows fed
CrPic,
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H ie variable response o f serum cholesterol and NEFA concentrations to
different C r compounds was not surprising. These two metabolites have been
reported to be decreased (cholesterol, Page et al., 1993; NEFA, Amoikon et al.,
1995), increased (cholesterol, Evock-Clover et al., 1993; Amoikon et a l., 1995), or
unchanged (cholesterol, Lindemann et al., 1995) in pigs fed supplemental CrPic.
However, the reduction in serum NEFA from CrPic-1 supplementation but not
CrPic-2 is surprising since these were identical chemical compounds differing only
in their source.
The variability in other metabolites and hormones also has been reported in
pigs (Evock-Clover et al., 1993; Page et al., 1993; Lindemann et al., 1995), sheep
(Gentry et al., 1995; Kitchalong et al., 1995; Ward et a l., 1995) and cattle (Bunting
et al., 1994; DePew et a l., 1995). The reason(s) for these variable responses is not
known.
Tigsiift M inerals

The lack o f an increase in muscle Cr content from supplemental dietary Cr is
in agreement with other research (Anderson et al., 1989, 1994). Increased tissue
chromium concentrations could become a regulatory issue. However, because most
Americans and others from highly developed countries do not consume the
recommended daily safe and adequate intake o f Cr (Anderson, 1989), some
scientists consider increased Cr content o f animal protein as a means o f
supplementation o f human diets with Cr an acceptable method o f increasing Cr

intake o f the population (Anderson et al., 1989). Nonetheless, mineral deposition
data are scarce and necessary. Overall, organic sources o f Cr resulted in higher
tissue Cr levels than the basal diet or CrCl. The exception is pancreas Cr. Pancreas
Cr levels were dramatically higher in pigs fed CrCl than in pigs fed the other dietary
treatments. Berggren and Flatt (1985) reported endocrine and exocrine pancreas Cr
concentrations five to sixty-fold higher than liver, kidney, skeletal muscle, cardiac
muscle, spleen, pituitary, testes and ovaries in rats fed CrCl. While it is generally
accepted that inorganic sources o f Cr are not absorbed as readily as organic sources
(Mertz, 1969; Votava et al., 1973), the pancreatic Cr pool does not exchange Cr
with the blood as rapidly as other tissues (Jain et al., 1981). Other investigators also
have reported increased Cr in kidney and liver but not in heart or muscle o f pigs fed
supplemental Cr as CrPic (Anderson et al., 1994). Anderson et al. (1994) also
reported no effect of CrPic supplementation on the concentration of zinc and iron in
muscle tissue o f pigs. Schrauzer et al. (1986) reported that mice fed Cr-rich
brewer’s yeast had increased Cr levels in the liver and heart. Chromium
supplementation also increased liver iron and decreased liver zinc concentrations. In
addition, mice fed Cr-supplemented diets had decreased manganese, iron, copper,
and zinc concentrations in the heart (Schrauzer et al., 1986).
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Im plications
Chromium addition to swine diets may not result in improvements in body
composition. Even though absorption and tissue retention of chromium seemed to
occur in the current investigation, changes in body composition were not observed.

CHAPTER IV
EFFECT OF DIETARY CHROMIUM SOURCE ON GLUCOSE TOLERANCE
AND INSULIN SENSITIVITY IN GROWING PIGS

Introduction
Chromium is most often associated with carbohydrate metabolism, being
necessary for insulin function for glucose uptake by cells (Anderson, 1985).
Chromium deficiency leads to glucose intolerance, and C r supplementation of the
diets o f elderly humans has resulted in improved glucose tolerance (Mertz, 1993).
Total parenteral nutrition patients also have been reported to have reduced diabetic
signs when given supplemental Cr (Jeejeebhoy et al., 1977; Brown et al., 1986).
Steele et al. (1977) reported that a synthetic glucose tolerance factor containing
C r enhanced the hypoglycemic action o f insulin in pigs. Dietary Cr as Cr
tripicolinate (CrPic) also has been shown to increase glucose disappearance rate (k)
and decrease glucose half-life (TI/a) in calves (Bunting et al., 1994) and pigs
(Amoikon et al., 1995). In pigs, CrPic has been shown to increase loin eye area
and decrease fat thickness (Lindemann et al., 1993; Page et a l., 1993a,b; Renteria
and Cuardn, 1993), and to increase the rate of lean and decrease the rate of fat
deposition (Mooney and Cromwell, 1993; Boleman et al., 1994). However, Cr
chloride hexahydrate (CrCl) did not affect carcass traits o f pigs (Page et al.,
1993a,b). Smith et al. (1994) reported that Cr nicotinate (CrNic) decreased backfat
thickness but did not affect loin eye area o f pigs. Thus, the form of Cr (inorganic or
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organic) also may affect the glucose responses that have been reported for livestock
species. Therefore, these experiments were conducted to determine the effect o f Cr
as CrCl, CrNic, or CrPic on glucose tolerance and insulin sensitivity in growing
pigs.
M aterials and M ethods
Animals anH nifttary TreatmpJits

Two identical trials were conducted. Crossbred (Yorkshire x Landracc
females bred to Hampshire boars) barrow pigs were used [Trial 1, n=36, avg.
initial body weight (BW )=20.2 kg; Trial 2, n=36, avg. initial BW =23.0 kg]. The
pigs were allotted to treatment on the basis o f weight in a randomized complete
block design; ancestry was equalized across treatments. Each treatment was
replicated three times in each trial with three pigs per replicate. Three pens o f three
pigs each per trial were fed a control diet without supplemental Cr. Trial 1 was
conducted from mid-November through mid-December 1994. Trial 2 was
conducted from mid-January through mid-February 1995.
The pigs were fed a com-soybean meal basal diet (Table 4.1) formulated to
provide 120% o f the NRC (1988) lysine requirement. The dietary treatments
consisted o f supplementing the basal diet with either 0 or 400 /tg Cr/kg diet from
CrCl (Sigma Chemical C o., St. Louis, MO), CrNic (provided by Dr. R. A.
Anderson, USDA, Beltsville, MD), or CrPic (CHROMAX™, Prince Agri Products,
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Table 4.1. Composition o f the basal diet* as-fed basis
Item

%

Com

73.01

Soybean meal, 44% CP

24.74

Limestone

1.06

Dicalcium phosphate

.64

Salt

.25

Vitamin premix*

.25

Trace mineral premixb

.05

‘Provided the following per kilogram o f diet: riboflavin, 4.4 mg; d-pantothenic acid,
22 mg; niacin, 22 mg; vitamin Bw, 22 ^g; d-biotin, 220 fi g; choline chloride, 440
mg; vitamin A, 4400IU; vitamin D}, 4 4 0 IU; vitamin E, 11IU; menadione
dimethylpyrimidinol bisulfite, .25 mg; Se, .1 mg.
‘’Provided the following per kilogram o f diet: Zn, 75 mg; Fe, 87.5 mg; Mn, 30 mg;
Cu, 8.75 mg; I, 1 mg; Ca, 9 mg.
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Quincy, IL). The pigs (three replicates of three pigs each) were allowed to consume
the treatment diets on an ad iihihim basis during the first 21 d o f the trials during
which time the pigs were group-penned in 1.8-m x 2.4-m pens in an enclosed
facility with totally slatted floors. After this growth period, five pigs per treatment
were randomly selected and moved into .6-m x 1.2-m plastic metabolism crates and
penned individually. H ie pigs were fed (feed mixed with water) twice daily an
amount approximating one-half their ad Iihihim intake. Growth performance data
were collected for the period prior to placing the pigs in the metabolism crates.
(Tathftterizatinn
After approximately 5 d in the metabolism crates, the pigs were anesthetized
i.m . with Telazol® (4.4 mg/kg BW, contains 2.2 mg tiletamine/kg BW as tiletamine
HC1 and 2.2 mg zolazepam/kg BW as zolazepam HC1; Fort Dodge Laboratories,
Inc., Fort Dodge, IA) plus Rompun® (4.4 mg xylazine/kg BW; Miles Inc., Shawnee
Mission, KS). A 12-gauge trocar was inserted into the right jugular fossa. A
catheter (Norton Tygon tubing No. AAQ04127; 1.02 mm i.d ., 1.78 mm o.d.;
Fisher Scientific, Pittsburgh, PA) was passed through the trocar and into the jugular
vein. The catheter was filled with a 6 % sodium citrate solution, sutured, and glued
to the skin o f the pigs at the point where the catheter exited the skin, routed to the
top o f the neck and held in place with surgical and duct tape. The total length of the
catheter was approximately 120 cm; approximately 10 to IS cm o f catheter was
inserted inside the jugular fossa, 40 cm was required to route the catheter to the top
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o f the neck, and approximately 70 cm of catheter was stored in a small pouch at the
top o f the neck for ease in blood collection.
M etabolic Challenges

Two to three d after catheterization, an intravenous glucose tolerance test
(TVGTT) was conducted followed 3 h later by an intravenous insulin challenge test
(IVICT) as outlined by Bunting et al. (1994). In both experiments, feed was
withheld for 15 to 18 h prior to the rVGTT. In brief, for the IVGTT and IVICT,
respectively, glucose (500 mg/kg BW) and insulin [. 1 U of crystalline porcine
insulin (Sigma #I-3505)/kg BW administered in a .9% NaCl solution containing .2%
bovine serum albumin (Fraction V Powder, Cat# 810-1018, Lot#A090767, Grand
Isle Biological C o., Grand Isle, NY) were administered via the jugular vein catheter
as bolus doses. Blood samples were collected via syringe and placed into 7-mL
tubes containing 17.5 mg sodium fluoride and 14.0 mg potassium oxaJate
(Monoject®, Sherwood Medical, St. Louis, MO) at -1 0 ,0 ,5 , 15, 30, 45, 6 0 ,9 0 ,
and 120 min relative to dosing for the IVGTT. For the IVICT, additional samples
were taken at 10, 20, 25, 150, 180, 210, and 240 min. Glucose k (%/min) and Tll7
(min) were calculated between 15 and 30 min for the IVGTT, and between 0 and 30
min for the IVICT as a modification o f the method outlined by Kaneko (1989).
Insulin k and T 1/2 were calculated between 15 and 30 min for the IVGTT and the
IVICT.
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rhftm iral Analyses

Blood metabolites and insulin were measured in plasma from the 0 min blood
samples collected before the IVGTT test. All IVGTT and IVICT samples were
analyzed for insulin and glucose concentrations. Plasma was analyzed for glucose
(Sigma, 1990) and cholesterol (Sigma, 1989) concentrations, using
spectrophotometric procedures outlined in commercially-available kits (Sigma
Chemical C o.). Plasma urea N concentrations were determined
spectrophotometrically using the urease procedure outlined by Fernandez et al.
(1988), and plasma NEFA concentrations were determined using a commercial
enzymatic procedure (NEFA-C Kit, ACS-ACOD Method; Wako Chemicals USA,
Inc., Richmond, VA). All samples were assayed in duplicate and measurements
resulting in errors greater than 5% were re-analyzed.
Plasma insulin was assayed by the RIA method o f Amoikon et al. (1995).
Guinea pig anti-bovine insulin antiserum (Code No. 65-101, Lot No. GP616; ICN
ImmunoBiologicals, Lisle, IL) was used at a 1:60,000 final dilution. Purified
porcine insulin (26.1 jiU/ng; Sigma Chemical Co.) and bovine 12SI-insulin (ICN
Biomedicals, Inc., Costa Mesa, CA) were used as the standard and radioligand,
respectively. Sheep anti-guinea pig antiserum produced in our laboratory was used
at a 1:4 dilution as the precipitating antibody. The intraassay and interassay CV for
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the insulin RIA as determined by pooled bovine plasma samples were 14% and
13%, respectively.
Statistical A naly.w

Data from these experiments were analyzed by ANOVA (Steel and Torrie,
1980) using the GLM procedure of SAS (1985). The growth performance data were
analyzed as a randomized complete block design with initial weight as blocks and
the pen o f pigs was the experimental unit. The metabolite and insulin data were
analyzed as a completely random design and the individual pig was the experimental
unit. Common criteria for Trials 1 and 2 were found not to contain trial by
treatment interactions, therefore the data were pooled for statistical analyses and
presentation.
Results and Discussion
Average daily gain (ADG), average daily feed intake (ADFI) and gain/feed
were not affected (P > .10) by dietary treatment (Table 4.2). These results are in
agreement with other research conducted using pigs (Amoikon et al., 1995; EvockClover et al., 1993; Lindemann et al., 1993; Page et al., 1993a,b; Renteria and
Cuardn, 1993), lambs (Kitchalong et al., 1995), and calves (Bunting et al., 1994).
Plasma cholesterol, NEFA, urea N, and insulin were not affected (P > .05)
by treatment (Table 4.3). Reduced levels o f circulating total cholesterol have been
reported in pigs (Page et al., 1993a) and calves (Bunting et al., 1994) fed CrPic.
However, Evock-Clover et al. (1993) reported that supplemental dietary CrPic
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Table 4.2. Effect o f dietary chromium source on daily gain, feed intake, and
gain/feed in growing barrows (Trial 1 and Trial 2 combined)*
Treatment
Pooled
Criterion

Control

CrCl

CrNic

CrPic

ADG, kg

.84

.83

.86

.84

.02

ADFI, kg

1.98

2.01

1.98

2.00

.06

Gain/feed

.43

.41

.44

.42

.01

SEM

■Data are means o f six replicates with three pigs per replicate; avg. initial BW =
21.6 kg (Trial 1, 20.2; Trial 2, 23.0). The pigs were fed a com-soybean meal diet
without (Control) or with 400 /ig Cr/kg diet as Cr chloride hexahydrate (CrCl), Cr
nicotinate (CrNic), or Cr tripicolinate (CrPic). The growth trial period was 21 d.
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Table 4.3. Effect of dietary chromium source on plasma metabolites and hormones
in growing barrows*
Treatment
Pooled
Criterion

Control

CrCl

CrNic

CrPic

SD

Glucose, mmol/L

4.72* (11)

4.56' (9)

S.Otf (11)

4.77* (8)

.39

Cholesterol, mmol/L

2.31 (11)

2.38 (9)

2.31 (11)

2.36(11)

.34

Urea N , mmol/L

6.04 (11)

5.81 (9)

5.39 (11)

5.97 (8)

1.28

NEFA, mEq/L

•59 (9)

.61 (9)

.57 (9)

•71 (5)

.29

Insulin, /zU/mL

4.18(11)

4.39(11)

4.77 (8)

2.46

4.13(9)

*The pigs were fed a com-soybean meal diet without (Control) or with 400 ftg Cr as
Cr chloride hexahydrate (CrCl), Cr nicotinate (CrNic), or C r tripicolinate
(CrPic)/kg diet. The number o f barrows is shown in parentheses. Plasma samples
were collected after 15 to 18 h without feed.
‘“Means within a row without a common superscript differ, P < .05.
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increased total cholesterol and high-density lipoprotein(HDL)-cholesterol in pigs.
Amoikon et al. (1995) also reported increased total cholesterol and decreased
NEFAin pigs fed CrPic. Chromium supplementation in humans also has yielded
variable effects on cholesterol components (Riales and Albrink, 1981; Anderson et
al.* 1983; Evans, 1989; Lefavi e ta l., 1993). Chromium compounds have been
reported to lower serum triacylglycerol (Ranhotra and Gelrotb, 1986) and NEFA
(Mirsky, 1993) in rats.
During the IVGTT, glucose k and glucose T l/2 were not affected (P > . 10) by
treatment (Table 4.4).

In a similar manner, during the IVICT, glucose k and

glucose TI/2 were not affected (P > .10) by dietary treatment. The response curves
depicting mean glucose concentrations over time during the IVGTT and I VICT are
shown in Figures 4.1 and 4.3, respectively.

The response curves depicting mean

insulin concentrations over time during the IVGTT and IVICT are shown in Figures
4.2 and 4.4, respectively. Amoikon et al. (1995) reported that pigs fed 200 jug Cr
as CrPic per kg diet had increased glucose clearance and decreased glucose half-life
during IVGTT. The reason(s) for the lack o f agreement between the data o f
Amoikon ct al. (1995) and the current experiment are not known. During the
IVICT (Table 4.5), insulin k and insulin T,^ were not affected (P > .10) by dietary
treatment. Amoikon et al. (1995) reported similar findings in pigs fed CrPic.
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Table 4.4. Effect of dietary chromium source on glucose kinetics in growing
barrows*_________________________________________________________
Treatment
Pooled
Criterion

Control

CrCl

CrNic

CrPic

SD

Intravenous Glucose Tolerance Test (IVGTT), 15-30 min
Clearance, %/min
Half-life, min

3.82(11)

4.02 (9)

3.40 (11)

3.05 (8)

1.28

20.32(11)

19.23 (9)

23.60(11)

24.80 (8)

7.33

2.64 (11)

2.25 (8)

.81

Intravenous Insulin Challenge Test (IVICT), 0-30 min
Clearance, %/min
Half-life, min

2.84 (11)

2.71 (9)

27.27(11)

27.82 (9)

29.31 (11) 33.73 (8) 10.45

“The pigs were fed a com-soybean meal diet without (Control) or with 400 ng Cr as
Cr chloride hexahydrate (CrCl), Cr nicoiinate (CrNic), or Cr tripicolinate
(CrPic)/kg diet. All data are means of individually fed pigs. Number o f barrows is
shown in parentheses.
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Table 4.5. Effect of dietary chromium source on insulin kinetics in growing
barrows*________________________________________________________
Treatment
Pooled
Criterion

Control

CrCl

CrNic

CrPic

SD

Intravenous Glucose Tolerance Test (IVGTT), 15-30 min
Clearance, %/min
Half-life, min

7.72(11)

9.05(9)

6.57(9)

5.55 (5)

4.35

15.76(11)

10.44(9)

14.22(9)

13.46 (5)

7.60

Intravenous Insulin Challenge Test (IVICT), 15-30 min
Clearance, %/min
Half-life, min

6.45(11)

6.77(9)

6.95 (11)

5.12(8)

2.44

11.74(11)

10.73(9)

11.09(11)

17.76(8)

5.29

T h e pigs were fed a com-soybean meal diet without (Control) or with 400 /*g Cr as
Cr chloride hexahydrate (CrCl), Cr nicotinate (CrNic), or C r tripicolinate
(CrPic)/kg diet. All data are means o f individually fed pigs. Number o f barrows is
shown in parentheses.

55

16 C ontrol
C rC l
CrNic
CrPic

14 eS 12 H

a

u 10

-

9

•a
*

a

8« H
6

-

4 -

2

I
0

20

i
40

~ r~
60

—r~
80

— I—

100

120

Tim e, min.

Figure 4.1. Effect o f dietary chromium on glucose tolerance in pigs during an
intravenous glucose tolerance test. Pigs were fed a com-soybean meal control diet
without ( • ) or with 400 fig C r as CrCl (■ ), CrNic (A ), or CrPic (T )/kg diet. For
glucose disappearance rate: pooled SD = 1.27; and for glucose half-life; pooled
SD = 7.32.
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Figure 4.2. Effect o f dietary chromium on insulin clearance in pigs during an
intravenous glucose tolerance test. Pigs were fed a com-soybean meal control diet
without ( • ) or with 400 fig Cr as CrCl (■ ), CrNic (A ), or CrPic (Y )/kg diet. For
glucose insulin disappearance rate: pooled SD = 4.35; and for insulin half-life;
pooled SD = 7.60.
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Figure 4.3. Effect o f dietary chromium on glucose clearance in pigs during an
intravenous insulin challenge test. Pigs were fed a com-soybean meal control diet
without ( • ) or with 400 /*g Cr as CrCl (■ ), CrNic (A ), or CrPic (T )/kg diet. For
glucose disappearance rate: pooled SD = .81; and for glucose half-life; pooled
SD = 10.45.
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Figure 4.4. Effect of dietary chromium on insulin clearance in pigs during an
intravenous insulin challenge test. Pigs were fed a com-soybean meal control diet
without ( • ) or with 400 /xg Cr as CrCI (■ ), CrNic (A ), or CrPic (▼)/kg diet. For
glucose insulin disappearance rate: pooled SD — 2.44; and for insulin half-life;
pooled SD = 5.29.
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Steele et al. (1977) demonstrated that Cr-containing GTF increases insulin
sensitivity in pigs. These authors concluded that GTF was biologically active in
swine and that it potentiated the insulin-insulin receptor interaction. Beneficial
effects of Cr-rich yeast on glucose tolerance and insulin sensitivity in elderly people
have been reported (Offenbacher and Pi-Sunyer, 1980). Riales and Albrink (1981)
reported that supplementation with Cr as CrClj‘6H20 improved insulin sensitivity in
subjects with insulin resistance, but in not subjects with normal glucose tolerance.
Abraham et al. (1992) also has reported no effect of dietary Cr supplementation (as
CrCI) on the glucose status o f patieuts with or without non-insulin-dependent
diabetes. However, the most prominent data regarding Cr supplementation is (hat
glucose intolerance has been associated with Cr deficiency (Schioedcr, 1966;
Stoecker and Oladut, 1985; Anderson, 1987). Chromium supplementation has been
found to be essential for normal glycemia and insulin function in human patients
receiving long-term total parenteral nutrition (Jeejeebhoy et al., 1977; Brown et al.,
1986).
Bunting et al. (1994) reported that Cr as CrPic increased glucose k in cattle;
however, both Kitchalong et al. (1995) and Fomea et al. (1994) reported no effect
o f dietary CrPic on glucose clearance rates in lambs. Evock-Clover et al. (1993)
reported that dietary CrPic "normalized” plasma glucose and insulin in pigs injected
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with somatotropin. Thus, the conditions which affect the glucose response to Cr
supplementation remain unknown.
The current study was conducted in the same facilities as those used by
Amoikon et al. (1995). Thus a reduction in stress due to better facilities as
hypothesized in the previous chapter of this dissertation is probably not valid in this
case. However, it is possible that genotypic changes or the Cr status of the pigs at
the Louisiana Agricultural Center Swine Unit have changed and thus may be
responsible for the discrepant responses.
Im plications
In this report, we have shown that chromium as chromium chloride, chromium
nicotinate, and chromium tripicolinate did not affect glucose tolerance or insulin
sensitivity in pigs. These results are not in agreement with other studies in which
both organic and inorganic sources o f chromium have been used to demonstrate the
importance o f chromium in insulin sensitivity in humans, pigs, and other animal
species. The reasons for the discrepant results o f chromium supplementation for pigs
and other livestock species remain unknown. Some speculate that the level of
environmental stress, genotype differences, or Cr status may account for the
differences in response to supplemental dietary chromium. The precise conditions
under which chromium benefits livestock must be characterized if chromium is to be
recognized as an essential feed additive.

CHAPTER V
INTERACTIVE EFFECTS OF DIETARY CHROMIUM TRIPICOLINATE
AND CRUDE PROTEIN LEVEL IN GROWING-FINSHING PIGS
PROVIDED INADEQUATE AND ADEQUATE PEN SPACE: EFFECTS ON
GROWTH PERFORMANCE, CARCASS CHARACTERISTICS, AND PLASMA
METABOLITES AND HORMONES

Introduction
Page et al. (1993a,b) reported that Cr tripicolinate (CrPic) decreased 10th rib
backfat thickness and increased longissimus muscle area in pigs. Other authors have
also reported improvements in body composition o f swine from supplemental dietary
CrPic (Renteria and Cuardn, 1993; Mooney and Cromwell, 1994; Boleman et al.,
1993; Lindcmann et al., 1995). Our laboratory (Boleman et al., 1995) as well as
Mooney and Cromwell (1995) has obtained equivocal results in improved linear
carcass measurements o f pigs fed supplemental, dietary Cr. Some investigators have
suggested that animals have to be under some form o f stress to elicit a response to
C r supplementation (Anderson, 1994; Mowat, 1994). Recently, we have conducted
several trials without obvious improvement in the linear carcass measurements in
response to supplemental Cr (unpublished data, and Ward et al., 1995; these
experiments were conducted in new finishing facilities). We hypothesized that the
production stress the pigs experienced was decreased over that of pigs in earlier
studies in which responses to Cr supplementation were found. One means o f
subjecting pigs to a chronic production stress would be to reduce the pen space
allowance per pig. Undemann et al. (1993) reported that the response to
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supplemental dietary Cr may be dependent on the lysine (or CP) content o f the diet.
Therefore, we conducted the following investigation to investigate the interactive
effects of dietary Cr, CP, and pen space allowance in growing-finishing pigs.
M aterials and M ethods
Animals and n le ta ry T reatments

Crossbred (Yorkshire x Landrace females bred to Hampshire boars) pigs were
used [avg. initial body weight (BW )=27.2 kg]. The pigs were allotted to treatment
on the basis of BW in a randomized complete block design; ancestry was equalized
across treatments. Each treatment was replicated four times with four pigs per
replicate pen. Four pens o f four pigs each were fed a control diet without Cr
supplementation. Sex (two gilts and two barrows) was equalized within pen.
A 2 x 2 X 2 factorial arrangement o f treatments was used. The pigs were fed
a com-soybean meal basal diet formulated to provide 80 or 120% of the lysine
requirement (NRC, 1988) during both the grower and finisher phases (Table 5.1).
The additional dietary factor was two levels o f Cr (none or 400 Mg Cr/kg diet as
CrPic; Chromax™, Prince Agri Products, Inc., Quincy, IL). The pigs were
allowed to consume the treatment diets on an adiihitum basis. The third treatment
factor was two areas of pen space (mVpig; adequate, .035 BW,(i7 kg, or inadequate,
.025 BW 67 kg; Whittemore, 1993). The pigs were weighed weekly and pen space
was adjusted at 10 kg o f BW gain increments on an individual pen basis. The pigs
were penned in a curtain-sided facility with totally slatted concrete floors. Each pen
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Table S .l. Composition of the basal diets, as-fed basis
Grower

Finisher

Percentage of Lysine Requirement
80

120

Item

80

120

%

Com

84.12

73.01

89.15

80.27

Soybean meal, 44% CP

13.44

24.74

8.87

17.91

1.05

1.06

.99

.99

Dicalcium phosphate

.84

.64

.44

.28

Salt

.25

.25

.25

.25

Vitamin premix'

.25

.25

.25

.25

Trace mineral premixb

.05

.05

.05

.05

Limestone

'Provided the following per kilogram of diet: riboflavin, 4.4 mg; d-pantothenic acid,
22 mg; niacin, 22 mg; vitamin B)2, 22 n g; d-biotin, 220 u%\ choline chloride, 440
mg; vitamin A, 4400IU; vitamin

I>3.

440 IU; vitamin E, 11 IU; menadione

dimethylpyrimidinol bisulfite, .25 mg; Se, .1 mg. Treatment diets were fed
without and with 400 //g Cr as Cr tripicolinate/kg diet.
bProvided the following per kilogram of diet: Zn, 75 mg; Fe, 87.5 mg; Mn, 30 mg;
Cu, 8.75 mg; I, 1 mg; Ca, 9 mg.
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contained a single-hole feeder and a single nipple waterer. The pen space allowance
calculations accounted for the space occupied by the feeder. Pigs were switched to
finisher diets when the average BW o f a pen was approximately 55 kg. The pigs
were removed from the experiment when die average BW of a pen was
approximately 104 kg. This experiment was conducted from the end o f August
1994 to the first wk o f January 1995.
B lnnd Sam pling

All pigs were bled via the anterior vena cava following 20 h without access to
feed and again 2 h postfeeding on d 21 o f the experiment. Blood for plasma
metabolites was placed into 7-mL tubes (Monoject®, Sherwood Medical, St. Louis,
MO) containing 17.5 mg sodium fluoride and 14.0 mg potassium oxalate. Blood for
plasma hormones was placed into 7-mL tubes (Monoject®) containing 10.5 mg
KjEDTA. All blood samples were placed in an ice bath immediately after
collection. The blood samples were centrifuged for 20 min at 1,600 X g at 4°C.
Plasma was collected and frozen (-20°C) for later analyses.
P-amass Traits

Pigs were killed via electrical shinning followed by exsanguination at the
Louisiana State University Agricultural Center Department o f Animal Science Meats
Laboratory. Hot carcass weights were taken with heads off the carcass and leaf fat
in the carcass. Longissimus muscle area (LMA) at the 10th rib interface and 10th
rib fat (TRF) thickness three-fourths the distance from the midline were measured
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after approximately 20 h at 2°C. Longissimus muscle area and TRF were adjusted
to 104.3 kg (NSIF, 1987), and percentage of muscling (PM) was calculated by
methods described by the NPPC (1991). Dressing percentage (DP) was calculated
by dividing hot carcass weight by live BW times 100.
Chemical Analyses
Plasma was analyzed for glucose (Sigma, 1990; Sigma Chemical Co.; St.
Louis, MO), total cholesterol (Sigma, 1989), and NEFA (NEFA-C Kit, ACSACOD Method; Wako Chemicals USA, Inc., Richmond, VA) concentrations using
spectrophotometric procedures outlined in commercially-available kits. Plasma was
analyzed for urea N by the urease method outlined by Fernandez et al. (1988).
Plasma insulin was assayed by the R1A method o f Amoikon et al. (1995).
Guinea pig anti-bovine insulin antibody (Code No. 65-101, Lot No. GP616; ICN
ImmunoBiologicals, Lisle, IL) was used at a 1:60,000 final dilution. Purified
porcine insulin (26.1 /xU/ng; Sigma Chemical Co.) and bovine 123I-insulin (ICN
Biomedicals, Inc., Costa Mesa, CA) were used as the standard and radioligand,
respectively. Sheep anti-guinea pig antibody produced in our laboratory was used at
a 1:4 dilution as the precipitating antibody. The intraassay CV for the insulin RIA
as determined by a pooled bovine plasma sample was 12.9%.
Plasma GH was measured by a double-antibody RIA technique based on
antibody (AFP-10318545; A.F. Parlow, Pituitary Hormone and Antisera Center,
Harbor-UCLA Medical Center, Torrance, CA) against porcine GH (pGH). Highly
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purified pGH was radioiodinated via the chloramine-T method (Greenwood et al.,
1963; 2.5 fig o f chloramine-T/ftg of GH, 0 °C for 30 s). The antiserum was diluted
1:150,000 in PBS containing .033 M EDTA, .112% normal rhesus monkey plasma
(Calbiochem, San Diego, CA), and 33% noninhibitory horse plasma; 300 /iL o f this
solution was used per tube. The horse plasma was added to minimize and to
stabilize nonspecific binding o f radioiodinated pGH to the assay tubes. Antiserum
(Calbiochem) against rhesus monkey immunoglobulin-G was diluted 1:21 and was
used at 200 ftL per tube to precipitate the primary antibody. Cross-reactivities of
other porcine pituitary hormones in the assay were as follows (percentage relative to
pGH): prolactin, .08; FSH, .12; LH, .001; and thyroid-stimulating hormone, .004
(A .F. Parlow, personal communication). Inhibition curves produced by serial
dilutions of porcine sera and pituitary extracts were parallel to those produced by the
reference standard (USDA-pGH-Bl; National Hormone and Pituitary Agency,
Baltimore, MD). Sensitivity o f the assay averaged . 1 ng; the sample size was 200
/*L in a typical assay. Intraassay CV in the GH RIA was 7.1% .
Statistical Analyses

Data from this experiment were analyzed by ANOVA (Steel and Torrie, 1980)
using the GLM procedure of SAS (1985). The data were analyzed as a randomized
complete block design with initial BW as the blocking factor. The pen o f pigs was
the experimental unit for all data. Statistical analysis of DP included final BW in
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the model as a covariate. Orthogonal single-degree-of-freedom contrasts were used
to evaluate the main effects and interactions.
Results
fim w th Performance

During the grower phase o f production, pigs fed 120% o f the lysine
requirement had greater (P < .01) average daily gain (ADG) and gain/feed and
lower (P < .03) average daily feed intake (ADF1) than pigs fed 80% of the lysine
requirement (Table 5.2). Pigs provided inadequate pen space (.025 BW67 kg) had
lower ADG (P < .01), ADFI (P < .01), and gain/feed (P < .03) than pigs
provided adequate pen space (.035 BW 67 kg). Average daily gain was decreased to
a greater extent by inadequate pen space in pigs fed 80% of the lysine requirement
than in pigs fed 120% o f the lysine requirement (CP x pen space effect, P < .01).
Gain/feed was decreased by inadequate pen space in pigs fed 80% o f the lysine
requirement; however, in pigs fed 120% o f the lysine requirement inadequate pen
space increased gain/feed (CP X pen space effect, P < .08). Chromium
supplementation did not affect (P > .10) ADG, ADFI, or gain/feed during the
grower phase.
During the finisher phase, pigs fed 120% o f the lysine requirement liad less
(P < .10) ADFI but similar (P > .10) ADG compared with pigs fed 80% of the
lysine requirement. Gain/feed was higher (P < .10) in pigs fed 120% o f the lysine
requirement than in pigs fed 80% o f the lysine requirement. Average daily gain and

Table 5.2. Effect of dietary chromium, crude protein level, and pen space on growth performance and carcass characteristics of
growing-finishing pigs"______________
Percentage of lysine requirement
80
120
80
120
80
120
80
120
Cr, Mg/kg diet
0
0
400
400
0
0
400
400
Pot space allowance, m2/pigb
Pooled
.m
s
.035
.035
.035
.025 _ .025
SKM
__ .025
.025
£n
Grower phase
ADG, kg*-1*
.685
.750
.678
.728
.594
.715
.598
.696
.019
ADFI, kgv
2.101
2.077
2.006
1.982
1.951
1.898
1.935
1.853
.049
Gain/feed'4'5
.326
.374
.327
.368
.304
.307
.376
.376
.004
Finisher phase
ADG, kg^
ADFI, kg?'*
Gain/feetf*
Overall
ADG, kg***
ADFI, kg^
Gain/feede,h
(table con'd)

.833
3.472
.240

.839
3.115
.269

.859
3.283
.261

.826
3.367
.249

.732
3.112
.238

.767
2.878
.267

.781
3.147
.250

.756
2.974
.255

.019
.136
.010

.774
2.915
.265

.805
2.689
.299

.789
2.811
.280

.788
2.802
.283

.674
2.617
.258

.747
2.521
.297

.701
2.612
.268

.734
2.536
.289

.016
.080
.007

Carcass characteristics
LMA, cm26*
35.0
35.7
30.4
30.0
31.4
35.7
32.1
33.5
.8
TRF, cme,w
3.1
2.5
2.5
2.7
2.9
2.6
2.0
2.3
.1
PM, %e>f
47.7
49.0
50.9
45.9
49.1
45.8
51.6
47.7
.5
75.2
DP. %
74.6
75.5
75.0
74.9
75.3
75.4
75.0
.5
'Data are means of four replicates of four pigs per replicate; average initial BW = 27.2 kg ; LMA=longissimus muscle area,
TRF=tenth rib fat thickness, PM=percentage of muscling, DP= dressing percentage.
bWhittemore, 1993. Adequate pen space, m2/pig = .035 BW-*7, kg; Inadequate pen space (crowded), m2/pig = .025 BW'67, kg.
*CP effect, P < .01.
*0? effect. P < .03.
*CP effect, P < .10.
'Pen space effect, P < .01.
*Pen space effect, P < .03.
hCP x Cr effect, P < .05.
*CP x Cr effect, P < .09,
jCP x pen space effect, P < .01.
‘‘CP x pen space effect, P < .08.
'Cr x pen space effect, P < .07.
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ADFI were lower (P < .01) in pigs provided inadequate pen space than in pigs
provided adequate pen space. Gain/feed was not affected (P > . 10) by pen space.
In pigs fed 80% o f the lysine requirement, Cr supplementation increased ADG and
gain/feed; however, in pigs fed 120% o f the lysine requirement Cr supplementation
decreased ADG and gain/feed (CP x Cr effect, P < .09 and P < .05,
respectively).
During the overall combined grower and finisher phases pigs fed 120% o f the
lysine requirement had higher (P < .01) ADG and gain/feed and lower (P < . 10)
ADFI than pigs fed 80% o f the lysine requirement. Pigs provided inadequate pen
space had lower (P < .01) ADG and ADFI, but similar gain/feed (P > .10), than
pigs provided adequate pen space. In pigs fed 80% o f the lysine requirement, Cr
supplementation increased gain/feed; however, in pigs fed 120% of the lysine
requirement Cr supplementation decreased gain/feed (CP x C r effect, P < .05).
Carcass Traits
Pigs fed 120% of the lysine requirement had greater (P < .01) LMA and PM
and less (P < .01) TRF than pigs fed 80% o f the lysine requirement (Table 5.2).
Pigs provided inadequate pen space had greater LMA (P < ,03) and PM (P < .01)
and less TRF (P < .01) than pigs provided adequate pen space. Chromium
supplementation increased TRF in pigs provided inadequate pen space; however, Cr
supplementation decreased TRF in pigs provided adequate pen space (Cr Xpen
space effect, P < .07).
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Plasma M rtahnlitre and H nrmnnea

Prefeeding. In pigs that were fed 120% o f the lysine requirement, plasma
glucose (P < .11), NEFA (P < .03), and urea N (P < .01) were greater, but
plasma cholesterol was lower (P < .01) than in pigs fed 80% of the lysine
requirement (Table S.3). Chromium supplementation decreased plasma NEFA
concentration of pigs fed 80% o f the lysine requirement but increased plasma NEFA
concentration of pigs fed 120% o f the lysine requirement (CP x Cr, P < .10). In
pigs provided inadequate pen space, increasing dietary lysine (120% o f requirement)
increased plasma glucose; however, in pigs given adequate pen space, dietary lysine
did not affect plasma glucose concentration (CP x pen space effect, P < . 11). In
pigs provided inadequate pen space, Cr supplementation decreased plasma insulin of
pigs fed 80% o f the lysine requirement but did not affect plasma insulin of pigs fed
120% o f the lysine requirement. However, in pigs provided adequate pen space, Cr
supplementation increased plasma insulin of pigs fed 80% of the lysine requirement
but decreased plasma insulin of pigs fed 120% o f the lysine requirement (CP X Cr
x pen space effect, P < .08). Plasma GH was not affected (P > . 10) by
treatment.
Pnstfeeding. In pigs that were fed 120% o f the lysine requirement, plasma
glucose (P < .11), NEFA (P < .11), cholesterol (P < .01), and GH (P < .01)
were lower, but plasma urea N and insulin were higher (P < .01) than in pigs fed
80% o f the lysine requirement (Table 5.3). In pigs provided adequate pen space, Cr

Table 5.3. Effect of dietary chromium, crude protein level, and pot space on plasma glucose, NEFA, insulin, and growth
hormone concentrations of growing-finishing pigs1_________________________________________________________
Percentage of lysine requirement
80
120
80
120
80
120
80
120
Cr. ue/kp diet
0
0
400
400
0
0
400
400
Pen soace allowance. m2/meb
Pooled
Criterion
.035
SEM
.035
.035
.025
.035
.025
.025
.025
Glucose, mmol/L
Unfed*
4.5
4.5
4.6
4.6
4.5
4.3
4.3
.1
4.5
Fed*
5.8
5.5
6.4
5.8
6.0
5.9
6.0
5.7
.3
NEFA, mEq/L
Unfed44
Fed*
Insulin, pU/mL
Unfed"
Fed*4

.64
.i6

.73
.12

.57
.14

.80
.13

.74
.16

.72
.14

.59
.17

.76
.13

.07
.02

6.0
19.1

4.4
28.0

4.1
17.5

4.5
38.4

3.8
15.4

5.6
41.8

7.0
21.3

5.1
32.1

1.1
5.7

Growth hormone, ng/mL
Unfed
9.5
11.4
Fed*

7.7
9.7

6.6
11.9

4.7
8.5

7.4
13.8

4.4
7.7

6.4
12.2

6.8
8.9

1.6
1.8

7.9
9.5

5.5
5.6

7.9
8.0

5.2
6.0

8.3
8.5

4.9
5.7

8.4
8.5

.5
.5

Urea nitrogen, mmol/L
Unfed*
5.5
Fed*
5.8
(table con’d)

Cholesterol, mmol/L
Unfed6
2.6
2.2
2.5
2.1
2.6
2.2
2.7
2.2
.1
Fed6_____________ 2.7
2.3
2.5
23
2.6
2.3
2.7
2.4
.1
'Data are means of four replicates with four pigs per replicate; average initial BW = 27.2 kg; Unfed = 20 h without access to
feed; Fed - 2 h postfeeding.
bWhittemore, 1993. Adequate pen space, m2/pig = .035 BW 67 kg; Inadequate pen space (crowded), m2/pig = .025 BW 67 kg.
6CP effect, P < .01.
"CP effect, P < .03.
'CP effect, P < .11.
fCP X C r effect, P < .10.
*CP x pen space effect, P < .11.
bCP x Cr x pen space effect, P < .08.
*CP x Cr x pen space effect, P < .10.
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supplementation decreased plasma insulin o f pigs fed 80% o f the lysine requirement
but did not change plasma insulin o f pigs fed 120% of the lysine requirement.
However, in pigs provided adequate pen space, Cr supplementation increased
plasma insulin of pigs fed 80% of the lysine requirement but decreased plasma
insulin o f pigs fed 120% of the lysine requirement (CP x Cr x pen space effect,
P < .08).
Discussion

The literature shows varied growth performance responses to Cr
supplementation o f pig diets. Page et al. (1993b) reported either decreased growth
performance or no effect of Cr supplementation in separate experiments.
Lindemann et al. (1995) reported that 250 and 500 ppb Cr as CrPic tended to reduce
ADFI without affecting ADG, resulting in an increase in gain/feed ratio. However,
Evock-Clover et al. (1993) reported no effect of CrPic on ADG, ADFI, or
gain/feed. Mooney and Cromwell (1995) reported that CrPic increased ADG but
did not affect ADFI or gain/feed. The current data are consistent with those of
lindem ann (1993) whereby Cr supplementation of diets that are deficient in lysine
(or at least marginally so) improves feed efficiency (and ADG, finisher phase only).
The mechanism responsible for this effect is not known; however, the involvement
o f Cr in RNA and DNA synthesis (Okada et al., 1984) may be responsible or an
increase in amino acid uptake (Hegsted et al., 1995).
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The effects o f crowding on the growth performance of pigs are known
(Komegay and Notter, 1984; NCR-89, 1986). Crowding previously has been
reported to reduce growth performance o f pigs primarily through its effect of
reducing feed intake (Komegay et al., 1993; Moser et al., 1985; NCR-89, 1986).
However, there has been some discussion as to whether increasing the nutrient
density o f pigs diets could overcome the effects of some stressor (e.g., crowding)
(Baker, 1995). Our data indicate that increasing the CP content o f the diet will
improve growth performance o f pigs that have been subjected to crowding.
Carcass Traits

As expected, the pigs fed lysine (and CP) adequate diets had greater LMA and
less TRF than pigs fed inadequate lysine. The presence of adequate or perhaps
excess dietary amino acids coupled with the increased feed efficiency o f pigs fed
120% o f the lysine requirement were probably responsible for this dramatic effect.
However, the improved carcass traits o f pigs that were given inadequate pen space
was not necessarily expected. The response was probably due not only to decreased
ADFI o f crowded pigs but also a generally slower growth rate. Another possible
cause o f the reduction in TRF may have been a reduction in glucose utilization by
the adipose tissue with subsequent reduction in lipogenesis as reported by
Rosebrough and Steele (1986). However, feed efficiency o f crowded pigs was
decreased or not affected by crowding. One would expect that an increase in feed
efficiency would be coupled with increased carcass lean. Zimmerman (1995)
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reported similar increases in muscling and decreases in fat due to reducing pen space
in pigs fed to 136 kg.
We had originally hypothesized that stressed (i.e., crowded) pigs may respond
to C r supplementation more readily than unstressed (i.e., uncrowded). However, no
main effects o f C r supplementation were observed for carcass traits. In fact, Cr
supplementation o f crowded pigs tended to make the carcasses o f those pigs fatter
(i.e., increased TRF). It may be that some other form o f stress is necessary or that
the pigs adapted to the crowding situation and thus were not "stressed”. Another
possibility is that the linear carcass measurements were not sensitive enough to
detect differences in carcass composition. Boleman et al. (1995) and Mooney and
Cromwell (1995) have reported that CrPic supplementation o f pig diets resulted in
increased carcass lean and decreased carcass fat without measurable differences in
linear carcass measurements. In addition, the rate o f lean accretion was increased
and the rate o f fat accretion was decreased (Boleman et al., 1995; Mooney and
Cromwell, 1995).
Lindemann et al. (1993) reported that the level o f dietary CP may affect the
response obtained from Cr supplementation; pigs fed marginal levels o f CP (lysine)
had increased muscling and decreased fat in response to Cr supplementation.
However, Harris et al. (1995) reported no effect o f dietary CrPic on growth
performance or carcass characteristics o f pigs fed adequate and low CP diets. Some
investigators have hypothesized that pigs that have increased potential for lean gain
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may not be as responsive to C r supplementation as pigs with less potential for lean
gain (Roger Campbell, Prince Nutrition Conference, 1993). The pigs in the current
experiment had an average PM of 48.5% even with the low lysine treatments (pigs
with adequate lysine PM — 50.2% ). Previous studies that have demonstrated
positive responses to Cr supplementation have typically used pigs with PM in (he
low to mid 40% ’s (Page et al., 1993a,b). The specific conditions necessary to elicit
improved carcass characteristics or carcass composition of pigs fed supplemental Cr
are not known. However, as we previously hypothesized (see Chapter 1 and 2), the
level o f stress, genotype, or Cr status may affect the response to Cr
supplementation.

Both insulin and glucose have been reported to reduce plasma NEFA
concentrations (Dole, 1956). Therefore, the increased plasma NEFA after 20 h
without access to feed in pigs fed 120% o f the lysine requirement compared with
pigs fed 80% o f the lysine requirement is an enigma. These pigs tended to have
higher plasma glucose but lower plasma insulin concentrations than pigs fed 80% o f
the lysine requirement. One would expect that die lower carcass lipid stores (lower
TRIO would have resulted in less adipose stores for NEFA mobilization. In fact,
this seems to be the case in the 2 h postfeeding samples. Pigs tied 120% of the
lysine requirement had higher plasma insulin and lower plasma NEFA
concentrations. Atinmo et al. (1978) reported that protein-malnourished pigs failed
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to respond to arginine-induced insulin release. Furthermore, protein-malnourished
pigs had higher NEFA levels than control pigs. These findings support the current
data, in which pigs fed 80% o f the lysine requirement had lower plasma insulin and
higher plasma NEFA concentrations 2 h postfeeding than pigs fed 120% o f the
lysine requirement. In addition, growth hormone is associated with increased
lipolysis (Keller and Miles, 1991) and may be involved in the higher plasma NEFA
levels o f pigs fed 80% o f the lysine requirement compared with pigs fed 120% of
the lysine requirement. Plasma urea N was higher in pigs fed diets containing
adequate (probably excess) amino acids. These effects have been reported
previously (Ward and Southern, 1993).
Lindemann et al. (1995) reported that dietary Cr supplementation diminished
the insulin response to feeding in gestating gilts. Evock-Clover et al. (1993) also
reported that dietary Cr tended to “normalize" glucose and insulin concentrations in
pigs injected with ppST. The changes in plasma insulin may depend on both the
nutritional and environmental status o f the pig, as well as other factors. For
example, dietary Cr appeared to accentuate the protein-induced increase in plasma
insulin o f uncrowded pigs. However, dietary Cr supplementation somewhat
modulated the protein-induced increase in plasma insulin of crowded pigs. Thus the
ability o f a pig to respond to supplemental Cr may depend on the overall health and
nutritional status o f the pig.
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Amoikon et al. (1995) reported that dietary Cr supplementation decreased
plasma NEFA level o f growing pigs. In the present investigation, the metabolic
response to dietary Cr supplementation again appeared to depend on the nutritional
status o f the pig. Dietary Cr supplementation was effective in reducing plasma
NEFA o f pigs fed inadequate lysine, but dietary Cr increased plasma NEFA levels
o f pigs fed adequate lysine. The differences in nutritional or environmental status o f
pigs may partially account for the varied responses in the literature.
Im plications
The assertion that dietary chromium may alleviate “stress” in animals or that
“stressed” animals may respond in a positive manner to chromium supplementation is
not apparent in pigs in which restricted pen size is the stressor. However, under
conditions in which pigs are fed diets which arc inadequate or marginally adequate
in amino acids (or protein), supplemental dietary chromium may result in improved
growth performance. Thus, the economic benefits o f supplementing pig diets with
chromium may depend on the production environment and availability o f adequate
dietary protein as well as other factors.

CHAPTER VI
EFFECT OF DIETARY CHROMIUM TRIPICOLINATE ON GROWTH
PERFORMANCE, BODY COMPOSITION, PLASMA METABOLITES
AND HORMONES, AND GLUCOSE TOLERANCE AND INSULIN
SENSITIVITY IN BROILERS

Introduction
Chromium is known to influence protein, lipid, and carbohydrate metabolism,
and it has been'shown to promote growth in turkey poults (Steele and Rosebrough,
1979, 1981; Rosebrough and Steele, 1981) and to increase N utilization in lambs
(Britton et al., 1968). Recently, Cr supplementation of swine diets was reported to
increase carcass muscling and decrease tenth rib fat thickness (Lindemann et al.,
1993, 199S; Page et al., 1993a,b). Boleman et al. (1995) and Mooney and
Cromwell (1995) also have reported that dietary Cr increased the rate o f lean
deposition and decreased the rate o f fat deposition in pigs.
Consistent reduction of the fat content of broiler carcasses has eluded the
poultry industry. Chromium is capable o f facilitating the action of insulin (Mertz,
1969); therefore, it may be efficacious in modulating insulin and glucose
metabolism. Lower plasma glucose and higher plasma insulin has been associated
with increased body fat in growing broilers (Touchbum et a l., 1981). Because of
the association o f Cr with nutrient utilization and improvements in body composition
(increased muscling and decreased fat), it may be possible to supplement broiler
diets with Cr and achieve improvements (increased lean and decreased fat) in carcass
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composition. Therefore, these experiments were conducted to determine the effect
o f dietary Cr as CrPic on growth performance, carcass composition, and glucose
clearance rate in broilers.
M aterials and Methods
Three experiments were conducted to determine the effects o f dietary Cr as Cr
tripicolinate (CrPic) on growth performance and body composition o f broilers. An
additional experiment was conducted to determine the effect o f dietary CrPic on
glucose clearance rate and insulin sensitivity of broilers. Unless otherwise indicated,
all birds were housed in heated starter batteries during the first 2 weeks (wk) of each
experiment and moved to grower batteries during the ensuing experimental periods.
Battery pens were housed in an environmentally controlled building. Starter
batteries, as well as the room in which both starter and grower batteries were
housed, contained continuous fluorescent lighting.
E xperim ent 1

An experiment was conducted using unsexed Arbor Acres x Arbor Acres
broiler chicks (Sanderson Farms, Laurel, MS) from 5 to 19 days o f age. From
hatching to 4 days posthatching, all chicks were fed a com-soybean meal diet (Table
6.1). After they were deprived o f feed overnight, chicks were weighed and
randomly assigned to treatments on the basis of body weight (BW; average initial
BW = 64.2 g). Each treatment consisted of four replicates o f five chicks each. A
control treatment (four pens o f five chicks each) without Cr supplementation was
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Table 6.1. Composition o f the basal diet, as-fed basis (Exp. 1)
I n g r e d i e n t _____________________________________________________ %
Com
Soybean meal, 44% CP
Com oil
Defluorinaled rock phosphate
Alfalfa leaf meal
Oyster shell flour
Salt
Vitamin-mineral premix1
DL-Methionine
M nS04'H 20
ZnC 03
Total

47.14
42.S0
5.00
2.1.0
2.00
.40
.40
.25
. 15
.05
.01
100.00

Nutrient
Calrnlatort

Crude protein
23.06
Calcium
.99
Total phosphorus
.79
Available phosphorus
.53
Methionine + cystine
.87
Lysine
1.28
Metabolizable energy, kcal/lcg
3,038
'Roche Chemical Division, Nutley, NJ 07110. Provided the following per kilogram of
diet: vitamin A (retinyl acetate), 6,614 IU; cholecalciferol, 1,653 IU; dl-a-tocopheryl
acetate, 7 IU; menadione, 1.5 mg; thiamine, 1.1 mg; riboflavin, 6.6 mg; niacin, 33.1 mg;
d-pantothenic acid, 11.0 mg; folic ad d , .7 mg; pyridoxine, 1.1 ing; d-biotin, .055 mg;
vitamin Bw, .011 mg; choline (as chloride), 551 mg.
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included. The basal diet was supplemented with 0, 200, or 400 Atg Cr/kg diet as
CrPic (12% Cr). Chicks were allowed ad lihitum access to feed and water.
Total fecal collections were taken from day 10 to 14 o f the experiment at 24 h
intervals. The feces were pooled by replicate, lyophilized, and ground. Kjeldahl
nitrogen (N) analysis was conducted on the feed and fecal samples. At the
termination of the experiment (day 14), individual chicks were weighed and pen
feed consumption was determined. All chicks were killed via cervical dislocation.
Three chicks per replicate were randomly selected and nmscle samples o f the breast
and leg were collected. The other two chicks per replicate were placed in plastic
bags and frozen for later whole-body compositional analyses. Moisture percentage
o f the muscle samples was determined after lyophilizing. Ether extract was
conducted by Soxhlet extraction (ethanol and diethyl ether, 20 h each). Kjeldahl N
analysis of the meat samples also was conducted. For whole-body composition,
chicks were defrosted, weighed, placed in a stainless-steel blender container, and
autoclaved for 90 min (121 °C and 1.27 kg/cm2). Samples were cooled for 15 min,
water was added (10% o f the chick weight), and the sample was blended until
smooth. Samples o f the slurry were dried in a forced-air oven (100°C for 16 h) for
dry matter (DM) determination. After drying the samples were placed in a muffle
furnace (600°C for 8 h) for determination o f ash. An additional sample was
lyophilized, ground, and analyzed for Kjeldahl N. Fat analysts of the slurry was
conducted by rapid analysis methodology using a CEM Model AVC 80 analyzer
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(AOAC, 1990). All whole-body analyses were conducted in duplicate and were
corrected for moisture content (i.e., expressed on a dry matter basis).
E xperim ent 2

Male Ross x Peterson broilers (Sanderson Farms, Laurel, MS) were allowed
a 4-d adaptation period as in Exp. 1. The chicks (average initial BW — 81 g) were
then randomly assigned to four dietary treatments: 1) com-soybean meal basal
(Table 6.2), 2-4) the basal diet plus 400, 1,600, or 16,000 g Cr as CrPic/kg diet.
Each treatment was replicated three times with five chicks per replicate pen. A
control treatment (three pens o f five chicks each) without C r supplementation was
included. The chicks were weighed weekly and pen feed intake was determined
weekly. The chicks were bled (approximately 3 mL) via wing vein puncture
following 12 h without access to feed (fasted) and again 2 h postfeeding on day 25
o f the experiment. The blood was placed into tubes (Monoject®, Sherwood
Medical, St. Louis, MO) containing 8 mg potassium oxalate and 10 mg sodium
fluoride and immediately placed on ice. The blood was centrifuged (1,600 x g for
20 min at 4°C) and the plasma was collected and frozen for later hormone and
metabolite analyses. The chicks were killed via CQj inhalation on day 28 o f the
experiment. The digestive tract of each chick was removed and cleaned o f contents.
In addition liver, heart, and ventriculus weights were recorded. The digestive tract
and organs were then placed into plastic “ziplock" bags with the carcass and frozen
for subsequent proximate analyses methods as in Exp. I.
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Table 6.2. Composition o f the basal diet, as-fed basis (Exp. 2)
Ingredient
Soybean meal, 44% CP
Com
Com oil
Alfalfa leaf meal
Dicalcium phosphate
Oyster shell flour
Vitamin-mineral premix*
Salt
DL-Methionine
Selenium premixb

Total

%
46.18
41.99
6.00
2.00
1.53
1.35
.25
.40
.20
.10

100.00

Nutrient
Calculated
Crude protein
23.00
Calcium
1.00
Total phosphorus
.69
Available phosphorus
.45
Methionine + cystine
.93
Lysine
1.36
Metabolizable energy, kcal/kg
3,039
'Provided the following per kilogram of diet: vitamin A (retinyl acetate), 11,000 IU;
cholecalciferol (deactivated animal sterol), 1,650 IU; dl-a-tocopheryl acetate, 8 IU;
menadione (menadione sodium bisulfite), .72 mg; thiamine (mononitrate), 1 mg; riboflavin,
4.4 mg; niacin, 33 mg; d-pantothenic acid (d-calcium pantothenate), 8.1 mg; folic add , .33
mg; d-biotin, .055 mg; vitamin B13, .011 mg; choline (as chloride), 382 mg; manganese
(oxide), 60 mg; zinc (sulfate), 44 mg; iron (ferrous sulfate), 20 mg; copper (oxide), 2 mg;
iodine (ethylenediamine dihydriodide), 1.2 mg; cobalt (carbonate), .2 mg; ethoxyquin, 125
mg.
'’Provided .1 mg Se per kilogram o f diet as NajSeOj.
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E x p erim en t
Male and female (two replicates o f five chicks of each sex; average initial
BW = 79 g) were randomly assigned to three dietary treatments. The chicks were
fed one of the following three diets: 1) a com-soybean basal diet (Table 6.3), 2) the
basal diet plus 400 p g C r as CrPic/kg diet, or 3) the basal diet plus 1,600 p g C r as
CrPic/kg diet. The diets were reduced in crude protein (CP) content as
recommended by the NRC (1994) at wk 3 and wk 6 of the experiment (Table 4.5).
The cliicks were weighed weekly and feed intake was determined weekly.
The chicks were bled (approximately 5 mL) via wing vein puncture
following 12 h without access to feed (fasted) and again 2 h postfeeding on day 45
o f the experiment. The blood was placed into tubes (Monoject®) containing 14 mg
potassium oxalate and 17.5 mg sodium fluoride and immediately placed on ice. The
blood was centrifuged (1,600 x g for 20 min at 4°C) and the plasma was collected
and finozen for later hormone and metabolite analyses. The birds were killed via
CQt inhalation on day 49 o f the experiment. The digestive tract of each chick was
removed and cleaned o f contents. Liver, heart, spleen, proventriculus, small and
large intestine, and ventriculus weights were recorded. Both breasts and the right
leg and thigh o f each bird were dissected of lean tissue. The lean tissue weight and
the abdominal fat pad weight o f each bird were recorded. The digestive tract,
organs, and dissected tissues were then placed into plastic “ziplock* bags with the
carcass and frozen for subsequent proximate analyses.

87

T^ble6;3;iCom^sitiOT^sA e^^d^eteiias^^!^M is_^^=3^
Wlf o f P.yppriment

Ingredient_____________________ (K3_____________ 3^>_______________ 6-7
Soybean meal, 4496 CP
Com
Com oil
Alfalfa leaf meal
Dicalcium phosphate
Oyster shell flour
Vitamin-mineral premix1
Salt
DL-Methionine
Selenium premixb

46.18
41.99
6.00
2.00
1.53
1.35
.25
.40
.20
.10

54.95
33.40
6.00
2.00
1.19
1.51
.25
.40
.20
.10

61.04
27.64
6.00
2.00
1.00
1.37
.25
.40
.20
.10

100.00

100.00

100.00

Crude protein
23.00
Calcium
1.00
Total phosphorus
.69
Available phosphorus
.45
Methionine + Cystine
.93
Lysine
1.36
Metabolizable energy, kcal/kg 3,039

20.00
.90
.63
.40
.85
1.13
3,141

18.00
.80
.56
.35
.79
.97
3,217

Total
Nutrient
Calculated

•Provided the following per kilogram of diet: vitamin A (retinyl acetate), 11,000 IU;
cholecalciferol (d-activated animal sterol), 1,650 IU; dl-a-tocopheryl acetate, 8 IU;
menadione (menadione sodium bisulfite), .72 mg; thiamine (mononitrate), 1 mg; riboflavin,
4.4 mg; niacin, 33 mg; d-pantothenic acid (d-calcium pantothenate), 8.1 mg; folic acid, .33
mg; d-biotin, .055 mg; vitamin B,a, .011 mg; choline (as chloride), 382 mg; manganese
(oxide), 60 mg; zinc (sulfate), 44 mg; iron (ferrous sulfate), 20 mg; copper (oxide), 2 mg;
iodine (ethylenediamine dihydriodide), 1.2 mg; cobalt (carbonate), .2 mg; ethoxyquin, 125
mg.
'’Provided . 1 mg Se per kilogram of diet as Na2Se03.
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P rox im ate A nalyses

In Exp. 2 and 3, three birds per replicate were selected at random for carcass
compositional analyses. The carcass, digestive tract, and tissues of each bird were
thawed, separated, and weighed. In Exp. 2 the digestive tract plus organs (Gut) and
in Exp. 3 the leg plus thigh meat (D ark), and breast meat (W hite), and Gut were
ground individually in a Hobart (Model No. A-200) grinder equipped with a .64 cm
die and then further ground in a food processor. Samples of the Gut, Dark, and
White were placed into 7.6-cm x 12.7-cm plastic "ziplock" bags. The remainder of
the carcass was placed into a stainless-steel container, enclosed with a plastic
cooking bag (Reynolds Metal Co., Richmond, VA), and autoclaved for 120 min
(121°C and 1.27 kg/cm2). The carcass was immediately blended until smooth and a
sample of the resultant slurry was placed into a 7.6-cm x 12.7-cm plastic "ziplock”
bag. Ten percent o f the Gut, Dark, and White tissues from each bird within a
replicate were included in the pooled sample. One percent o f the weight of each
carcass within a replicate was used for pooling. Pat and moisture analyses of each
o f the pooled samples (Gut, Dark, White, and carcass) were conducted by rapid
analysis methodology using a CEM Model AVC 80 analyzer (AOAC, 1990).
Duplicate samples o f the slurry were dried in a forced-air oven (100° C for 12 h) for
DM determination. After drying, the samples were placed in a muffle furnace
(5S0°C for 12 h) for determination o f ash. An additional sample was lyophilized,
ground, and analyzed for Kjeldahl N.
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Experim ent A

An experiment was conducted to determine the effect of dietary Cr as CrPic
on glucose tolerance and insulin sensitivity in mature broilers. Twenty-eight-day-old
unsexed Arbor Acres x Arbor Acres broilers (Sanderson Farms, Laurel, MS) were
used. From hatching to 28 days posthatching, all broilers were fed a com-soybean
meal diet (Table 6.1). After they were deprived of feed overnight, the broilers were
weighed and randomly assigned to treatments on the basis o f BW (average initial
BW = 976 g). Chicks were provided continuous fluorescent lighting and caged in
starter batteries with raised wire floors. The battery heaters were not used and every
other battery level was used to allow adequate space for the broilers. Each treatment
consisted o f four replicate pens o f five chicks each. The basal diet was
supplemented with 0 (a control treatment) or 200 ^g Cr/kg diet as CrPic. Chicks
were allowed ad lihitnm access to feed and water. The diets were changed at 6 wk
o f age as recommended (Table 6.4; NRC, 1994).
Growth performance [average daily gain (ADG), average daily feed intake
(ADFI), and gain/feed] was measured from 28 to 58 days o f age. On day 58, two
broilers per replicate were randomly selected to remain on treatment diets; the other
three broilers were killed via C 02 inhalation. The remaining broilers were fed the
treatment diets until approximately 11 wk of age. After being without feed
overnight, the broilers were fitted with brachial vein catheters. This was
accomplished by inserting a 16-gauge needle into the brachial vein and passing
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Table 6.4. Composition of the basal diets, as-fed basis (Exp. 4)
________ Wk o f Experiment
Ingredient___________________________3^6______________________ 6-11
Soybean meal, 44% CP
Com
Com oil
Defluorinated nock phosphate
Oyster shell flour
Vitamin-mineral p remix*
Salt
Selenium premixb
DL-Methionine

Total

57.04
33.97
6.04
1.40
.90
.25
.24
.10
.07

64.80
27.95
4.62
1.17
.88
.25
.24
.10

100.00

100.00

20.00
.90
.63
.40
.72
1.13
3.200

18.00
.80
.57
.35
.65
.97
3,200

Nutrient
f ’fllfinlateri

Crude protein
Calcium
Total phosphorus
Available phosphorus
Methionine + Cystine
Lysine
Metabolizable enerfiVTkcal/kg

"Provided the following per kilogram of diet: vitamin A (retinyl acetate), 11,000 IU;
cholecalciferol (d-activated animal sterol), 1,650 IU; dl-a-tocopheryl acetate, 8 IU;
menadione (menadione sodium bisulfite), .72 mg; thiamine (mononitrate), 1 mg; riboflavin,
4.4 mg; niacin, 33 mg; d-paiitothenic acid (d-calcium pantothenate), 8.1 mg; folic acid, .33
mg; d-biotin, .055 mg; vitamin B12l .011 mg; choline (as chloride), 382 mg; manganese
(oxide), 60 mg; zinc (sulfate), 44 mg; iron (ferrous sulfate), 20 mg; copper (oxide), 2 mg;
iodine (ethylenediamine dihydriodide), 1.2 mg; cobalt (carbonate), .2 mg; etlioxyquin, 125
mg.
'’Provided . 1 mg Se per kilogram o f diet as Na2Se03.

91
catheter tubing (i.d., .58 mm; o .d ., .965 mm; Intramedic®, Becton Dickinson &
C o., Parsippany, NJ) through the needle. The needle was then removed and the
tubing remained in the vein. The tubing was glued with "super glue” to the skin
under the wing, passed behind the wing, and taped to the back o f the bird. Birds
were held in individual pens during blood sampling.
After at least 1 h rest, the broilers were given a bolus dose o f .88 g glucose/kg
BW intravenously (TVGTT) as a 50% solution in .9% NaCl. Blood samples were
collected at -10, 0, 5, 10, 15, 20, 25, 30, 45, 60, 90, 120, 150, 180 min relative to
glucose infusion. The blood was placed into tubes containing 10 mg sodium
fluoride and 8 mg potassium oxalate and immediately placed in an ice bath. The
blood samples were centrifuged (1,600 x g for 20 min at 4°C) and the plasma wits
collected and frozen for later hormone and metabolite analyses. At least 2 h after
the last sample was collected in the IVGTT, an intravenous insulin challenge test
(TVTCT) was conducted. The broilers were administered i.v. 1.5 U bovine insulin
(Sigma Cat.# 1-5500, Lot# 112H0353, Sigma Chemical Co., St. Louis, MO)/kg BW
as a bolus dose. The insulin was administered as a solution containing 13.5 U/niL
in .9% NaCl containing .2% bovine serum albumin (Fraction V Powder, Cat.# 8101018, Lot# A090767, Grand Isle Biological C o., Grand Isle, NY). Blood samples
were collected in the same manner as the IVGTT and at the same time points
relative to i.v. infusion o f insulin.
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Glucose clearance rate (k, %/rain) and half-life (min) were calculated between
IS to 45 min and 0 to 60 min for the IVGTT and IVICT, respectively, as a
modification of the procedure outlined by Kaneko (1989). Insulin clearance rate (k,
%/min) and half-life (min) during the IVGTT were calculated from 15 to 30 min.
Approximately 2 d after the IVGTT and IVICT, a least sampling minimal
model glucose tolerance test (LSMM) was conducted (Ader et al., 1985; Bergman,
1989). This procedure amounts to a combination IVGTT and IVICT. The basis o f
such a procedure is to separate, via computer analysis, the insulin and glucose
effects on glucose clearance from the plasma. The techniques have been used
successfully in mammals (Ader et al., 1985; Yang et al., 1987; Bergman, 1989).
The methodology is similar to the IVGTT and IVICT previously conducted. The
broilers were administered i.v. .528 g glucose/kg BW at time 0. Blood samples
were collected as described previously except at -1 ,2 , 4, 8, 19,22, 30, 40, 50, 70,
90, and 180 min relative to glucose administration. In addition, at 20 min
postinfusion o f glucose, .75 IU bovine insulin/kg BW was administered i.v.
Chemical Analyses

Plasma cholesterol (Sigma, 1989), glucose (Sigma, 1990), and NEFA (TVGTT
-10 min samples only, NEFA-C Kit, ACS-ACOD Method; Wako Chemicals USA,
Inc., Richmond, VA) were analyzed using spectrophotometric procedures outlined
in commercially-available kits.
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Insulin was measured in plasma samples with a homologous radioimmunoassay
previously validated for chicken tissues (McMurtiy et al., 1983). Antiserum against
chicken insulin (supplied by J.P . McMurtiy, USDA, Beltsville, MD) was diluted
1:20,000 in normal guinea pig serum (1:400), and 200 #*L of this solution was used
per tube. Highly purified chicken insulin (obtained from D.J. Bolt, USDA,
Beltsville, MD) was radioiodinated via the chloramine-T method (Greenwood et al.,
1963), and was used at approximately 40,000 cpm/tube. An aliquot o f the highly
purified hormone was diluted to 10 ng/mL and used as the reference standard. For
assay, samples (between 100 and 200 /iL) and standards were mixed with the first
antibody and were incubated *24 h. All incubations were at S°C. After addition of
labeled hormone, the tubes were vortexed and then incubated *24 h. Diluted (1: IS)
antiserum generated in a sheep against guinea pig gamma-globulin was added, and
the tubes were vortexed and incubated *48 h. The precipitated insulin-antibody
complexes were harvested by centrifugation after addition o f 2 mL o f .01 M
phosphate-buffered .155 M saline. Serial dilution o f chicken plasma produced an
inhibition curve in the assay parallel to the reference standard, and recovery o f
purified chicken insulin added to a low-insulin plasma pool was 115%. Sensitivity
o f the assay was .02 ng; intra- and interassay coefficients o f variation averaged 8
and 10%, respectively. Due to the crossreactivity o f bovine insulin with the chicken
insulin assay, insulin analysis was not conducted on the IVICT or LSMM samples.
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Plasma immunoreactive glucagon was assayed as outlined by Gaskins et al.
(1991). Rabbit anti-porcine glucagon antibody (Unger 04A, Pool 1, Lot #22; R.H.
Unger, Southwestern Medical Center, The University o f Texas, Dallas, TX) specific
for small molecular weight (3,500 mol. wt.) glucagon was used at a final dilution of
1:112,500. Purified porcine-bovine glucagon (Product No. G-2450; Sigma
Chemical Co.) was the standard. Porcine 125I-glucagon (Product No. 07-152126;
ICN Biomedicals, Inc.) was the radioligand, and goat anti-rabbit immunoglobulin G
prepared in the laboratory o f Donald L. Thompson, Jr. (Louisiana State University
Agricultural Center, Baton Rouge, LA) was used at a 1:12 dilution as the
precipitating antibody. The intraassay CV as determined by pooled turkey plasma
samples was 5.8% .
Statistical A n a ly s e

The growth performance, organ and tissue weight, metabolite and hormone,
and carcass composition data were analyzed as completely random designs using the
pen as the experimental unit. In Exp. 3, the data were analyzed as a 3 x 2 factorial
arrangement o f treatments in a completely random design. The two factors were
three levels o f Cr and two sexes. In Exp. 4, the glucose and insulin clearance data
were analyzed as a completely random design using the individual bird as the
experimental unit. The LSMM data was analyzed as a split-plot in time with
replicate within treatment as the error term in the model to test for treatment effects.

Results
Experiment 1
Supplemental dietary Cr did not affect (P > .10) ADG, ADFI, gain: feed
ratio, or N balance fTable 6.5). Supplemental Cr did not affect (P > . 10) the
percentage of CP, moisture, or ether extract in breast and leg muscle samples. In
addition, C r supplementation did not affect (P > .10) whole-body CP, fat, or ash
percentage. However, dietary Cr supplementation decreased percentage of DM
(quadratic effect, P < .09). In addition, 200 Mg Cr/kg diet tended to decrease
(P < . 13) fat percentage compared with the control diet.
E xperim ent 2

Dietary Cr supplementation did not affect (P > .10) ADG, ADFI, or
gain/feed (Table 6.6). Chromium supplementation did not affect (P > .10) liver,
heart, o r abdominal fat pad weights; however, ventriculus weight was increased (Cr
cubic effect, P < .07) in broilers fed supplemental Cr. Dietary Cr supplementation
increased carcass ash percentage (Cr quadratic effect, P < .06); however, carcass
and Gut moisture, fat, CP, and Gut ash percentage were not affected (P > .10) by
dietary Cr supplementation. Dietary Cr supplementation did not affect (P > .10)
plasma NEFA, cholesterol, glucose, insulin, or glucagon concentrations in the fed
or fasted state.
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Table 6.5. Effect o f dietary chromium on growth performance, N balance, and breast and

legjnusd^n^wh^^bod^com^sition^^toJQ^^^^l^^lSJ^^EiJil

Dietary Cr, jug/kg
------------------------------------------------------------Item__________________ 0_____________200____________ 400_________
Growth performance
ADG, g/chick
26.8
26.8
26.6
ADFI, g/chick
36.7
36.6
36.7
Gain:feed
.731
.732
.725
N balance, g/chick/d
1.40
1.35
1.40
Breast
CP, %
Moisture, %
Ether extract, %

23.4
75.2
2.3

23.6
75.7

Leg
CP, %
M oisture, %
Ether extract, %

19.6
74.5
7.6

20.6

2.2

72.3
10.6

Pooled
SEM
.5
.5
.009
.04

23.6
75.3
2.5

.4
.3
.3

18.5
73.0
10.4

1.4
1.0
1.1

Whole-Body
28.9
29.7
.4
30.3
DM, %b
54.3
54.4
CP, % o f DM
55.9
1.0
29.2
1.1
Fat, % o f DM
31.3
28.6
.2
Ash. % o f DM
7.9
8.3
8.1
“Growth performance data are means o f four replicates o f Eve broilers each. Breast and leg
composition data are means o f four replicates of three chicks each and whole-body
composition data are means o f four replicates of two chicks each.
bCr quadratic effect, P < .09.
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Table 6.6. Effect o f dietary chromium on growth performance, organ weights, body
Dietary Cr, //g/kg
Item
Growth performance
ADG, g/chick
ADFI, g/chick
Gain:feed
Organ weights, % BW
Liver
Heart
Ventriculusb
Abdominal fat pad

0

400

1.600

16.000

Pooled
SEM

49.3
80.1
.615

49.2
81.5
.604

49.9
82.0
.608

49.1
80.5
.610

.8
1.2
.010

2.82
.64
1.57
.53

2.89
.62
1.78
.56

3.03
.66
1.84
.55

2.89
.63
1.83
.59

.11
.03
.05
.04

Body Composition
Carcass
Moisture, %
Fat, %
CP, % DM
Ash, % DM*

68.8
8.3
61.7
9.2

68.9
8.5
63.2
9.4

69.7
7.9
64.0
9.7

68.3
8.9
63.4
8.9

.7
.4
1.5
.2

Gut
Moisture, %
Fat, %
CP, % DM
Ash, % DM

71.8
6.2
68.4
5.0

72.8
4.7
68.1
5.0

73.9
5.0
65.4
4.9

72.5
5.9
64.5
4.7

1.0
1.0
3.3
.2

.397
2.9
11.79
1.13
621.1

.378
2.7
11.59
1.26
547.5

.389
2.6
11.96
1.07
489.0

.012
.1
.20
.19
48.8

Metabolites & hormones
Fed
.393
NEFA, mEq/L
Cholesterol, mmol/L 2.8
11.32
Glucose, mmol/L
Insulin, ng/mL
1.35
Glucagon, pg/mL 515.2
(table con’d)
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Fasted
NEFA, mEq/L
.620
.588
.547
.581
Cholesterol, mmol/L 2.6
2.7
2.4
2.6
Glucose, mmol/L
10.21
9.91
9.98
10.35
Insulin, ng/mL
.90
.96
.79
.82
Glucagon, pg/mL 736.7
794.5
668.9
810.1
94.1
•Data are means o f three replicates o f five broilers each; avg. initial wt. = 81 g.
bCr cubic effect, P < .07.
*Cr linear effect, P < .04, quadratic effect, P < .06.
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Experiment 3
During the first three wk, dietary Cr supplementation did not affect (P > .10)
ADG; however, gain/feed was increased (Cr quadratic effect, P < .06) in birds fed
supplemental Cr (Table 6.7). Males grewer faster and ate more feed than females
(Sex effect, P < .OS). During wk 0 to 3, males ate the most feed when fed the diet
containing 400 ppb Cr; however, females ale the least feed when fed the diet
containing 400 ppb Cr (Sex X Cr quadratic effect, P < .06). During wk three to
six, neither dietary Cr supplementation nor sex affected (P > .10) ADG, ADFI, or
gain/feed. During the last wk of tlie experiment, ADG and gain/feed were higher in
males than in females (Sex effect, P < .05). Dietary Cr supplementation increased
ADG and gain/feed (Cr linear effect, P < .04); however, ADFI was not affected
(P > .10) by dietary Cr supplementation. Males had the highest ADG when fed the
diet containing 400 ppb Cr; however, females had the highest ADG when fed the
diet containing 1,600 ppb Cr (Sex x Cr quadratic effect, P < .06).
Dietary Cr supplementation did not affect (P > .10) liver, heart, ventriculus,
pancreas, spleen, or small intestine weights (Table 6.8). Ventriculus weight as a
percentage of BW was greater in males than in females (Sex effect, P < .07).
Proventriculus weight was the lowest in males when fed 400 ppb Cr; however,
females had the highest proventriculus weight when fed 400 ppb Cr (Sex x Cr
quadratic effect, P < .05). Large intestine weight was greatest in males fed the diet

Table 6.7. Effect of dietary chromium on growth performance of 5 to 54-<lay-old broilers (Exp. 3)*
Male

Female

Dietary Cr. u s fk z
Pooled
Item_____________________0_________ 400_______ 1,600________ 0__________ 400________ 1,600
SEM
Growth performance
0-3 wk
ADG, g*
42.2
43.8
42.5
39.7
37.9
39.9
.9
ADFI, gW
66.0
66.2
64.3
62.9
58.7
60.1
1.3
Gainrfeed6*4
.639
.662
.660
.631
.646
.663
.008
3-6 wk
ADG, g
54.4
62.2
64.5
56.9
53.3
52.6
5.9
ADFI, g
128.4
138.7
140.0
128.2
126.3
131.6
9.5
Gaimfeed
.419
.449
.461
.444
.422
.401
.027
6-7 wk
ADG, ^
46.9
60.2
57.4
46.7
49.3
50.6
1.2
ADFI, g
149.4
166.3
163.0
131.1
153.7
155.3
10.9
Gain:feedb,c______________ 314________363________346________ 305________ 321________ 326_______ .007
'Data are means of two replicates of five broilers each; avg. initial wt. = 79 g.
*Sex effect, P < .05,
cCr linear effect, P < .04.
dCr quadratic effect, P < .06.
'Sex x Or linear effect, P < .05.
fSex x Cr quadratic effect, P < .06.
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containing 1,600 ppb Cr; however, large intestine weight was greatest in females fed
400 ppb Cr (Sex x Cr quadratic effect, P < .01).
Dietary Cr supplementation decreased leg meat as a percentage of BW in birds
fed 400 ppb Cr but increased leg meat as a percentage of BW in birds fed 1,600 ppb
Cr (Cr quadratic effect, P < .10; Table 6.8). Abdominal fat pad weight as a
percentage o f BW was decreased more in females fed 1,600 ppb Cr than males fed
1,600 ppb Cr (Sex X Cr linear effect, P < .09). Neither sex nor dietary Cr
supplementation affected (P > .10) breast or thigh meat as a percentage of BW.
During the fed state, males had higher plasma NEFA levels than females (Sex
effect, P < .08, Table 6.9). However, during the fasted state, females had higher
plasma NEFA levels than males (Sex effect, P < .03).

Plasma cholesterol was

increased by Cr supplementation during the fed (Cr linear effect, P < .07) and
fasted (Cr quadratic effect, P < .02) states. During the fasted state, plasma
cholesterol was higher in males than in females (Sex effect, P < .08). Plasma
insulin, in the fasted condition, was higher in females than in males (Sex effect,
P < .03). Plasma insulin, in the fasted state, was increased by Cr supplementation
(Cr quadratic, P < .02). In the fed state, plasma insulin concentration was not
affected (P > .10) by treatment. Plasma glucose and glucagon concentrations were
not affected (P > .10) by treatment in either die fed or fasted state.
Carcass moisture, in males, decreased as dietary Cr level increased; however,
in females, carcass moisture increased as dietary Cr level increased (Sex x Cr linear

Table 6.8. Effect of dietary chromium on organ and tissue weights of 5 to 54-dav-old broilers (Exp. 3)*
Female
Male

Item
Organ weight, % BW
Liver
Heart
Proveotriculusf
Ventriculusb
Pancreas
Spleen
Small intestine
Large intestine'

0

400

2.82
.50
.27
1.21
.16
.19
1.86
.47

2.46
.51
.25
1.07
.18
.17
1.88
.51

Dietary Cr. uzPes.
1,600
0
2.41
.52
.30
1.22
.19
.14
1.98
.61

2.11
.53
.27
1.30
.20
.15
2.03
.49

Tissue weight, % BW
11.94
12.07
12.36
12.82
Breast meat
2.92
2.82
3.36
3.00
Leg meaf
3.84
3.57
3.73
3.75
Thigh meat
1.82
Abdominal fat pad4
1.49
1.65
1.19
'Data are means of two replicates of five broilers each; avg. initial wt. = 79 g.
bSex effect, P < .07.
'Cr quadratic effect. P < .10.
dSex x Cr linear effect, P < .09.
'Sex x Cr quadratic effect, P < .01.
fSex x Cr quadratic effect, P < .05.

Pooled
SEM

400

1,600

2.37
.55
.29
1.38
.20
.15
2.05
.57

2.55
.55
.29
1.35
.17
.22
1.85
.49

.11
.02
.01
.06
.01
.02
.05
.01

11.70
2.74
3.34
1.79

13.49
2.93
3.91
1.25

.57
.10
.14
.15

Table 6.9. Effect of dietary chromium on plasma metabolites and hormones of 5 to 54-day-old broilers (Exp. 3)*
Male
Female
Dietary Cr. Mg/kg
Item
0
400
1,600
0
400
1,600

Pooled
SEM

Fed
Cholesterol, mmol/Ld
NEFA, mEq/L*
Glucose, mmol/L
Insulin, ng/mL
Glucagon, pg/mL

3.0
.33
12.6
.72
225.6

3.2
.33
12.0
.98
220.8

3.0
.32
12.5
.92
229.7

Fasted
Cholesterol, mmol/Lc,c
3.2
3.4
3.6
.51
NEFA, mEq/Lb
.49
.50
10.6
10.8
Glucose, mmol/L
10.8
.24
.36
Insulin, ng/mL**-*
.15
861.6
Glucagon. pg/mL
664.6
836.6
“Data are means of two replicates of five broilers each.
bSex effect, P < .03.
*Sex effect, P < .08
dCr linear effect, P < .07.
'Cr quadratic effect. P < .02.

3.0
.32
12.0
.98
485.9

2.9
.29
11.4
1.36
145.8

3.0
.28
11.8
1.13
358.8

.1
.02
.5
.19
118.3

3.4
-55
10.9
.44
1162.2

3.2
.59
10.5
.34
1095.4

3.1
.58
10.8
.34
714.0

.1
.03
.3
.04
232.2
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effect, P < .04) (Table 6.10). In males, carcass fat percentage increased as dietary
Cr level increased; however, in females, carcass fat percentage decreased as dietary
Cr level increased (Sex x Cr linear effect, P < .04). Carcass ash and CP, as a
percentage of DM, were not affected (P > .10) by treatment.
Gut moisture was higher in males than in females (Sex effect, P < .06) but
was not affected (P > .10) by dietary Cr supplementation. Gut fat percentage in
males was the highest when fed 400 ppb Cr; however, in females, dietary Cr
decreased Gut fat percentage (Sex x Cr quadratic effect, P < .03). Gut ash as a
percentage of DM was decreased as dietary Cr level increased (Cr linear effect,
P < .01). Gut CP as a percentage o f DM was not affected (P > .10) by treatment.
White meat moisture was higher in males than in females (Sex effect,
P < .06). White meat moisture, in males, decreased when fed 400 ppb Cr;
however, in females, white meat moisture increased when fed 400 ppb Cr (Sex x
Cr quadratic effect, P < .03). White meat fat and CP were not affected (P > .10)
by treatment. White meat ash percentage was higher in females than in males (Sex
effect, P < .06).
Dark meat moisture and CP were higher in females than in males (Sex effect,
P < .06). Dark meat CP as a percentage of DM was higher in females than in
males (Sex effect, P < .06). Dark meat fat and ash percentage were not affected
(P > . 10) by treatment.

I

*™^"“

Male
—

^ —

Female
— —

m

h

— «»»

Dietary Cr. ^g/kg
1,600
0

^ _

1,600

59.3
18.5
46.4
7.8

60.1
18.3
45.2
7.9

62.8
14.5
48.8
8.6

.6
.7
2.1
.3

70.6
8.3
59.2
5.2

65.5
12.5
51.5
4.7

67.0
9.6
58.1
5.3

66.8
9.4
57.0
4.2

.8
.7
3.7
.2

71.8
.4
83.5
5.1

68.8
.6
90.6
5.3

70.4
.3
92.0
5.5

70.4
.8
92.3
5.4

.3
.4
4.3
.2

61.2
17.4
47.1
8.4

61.6
16.7
51.8
8.5

Gut
Moisture, %h
Fat, %bAf
CP, % DM
Ash, % DM0

70.6
8.3
61.7
5.5

68.6
10.7
56.4
4.1

71.8
.3
87.5
4.9

71.5
.6
87.7
5.0

White meat
Moisture, %kAf
Fat, %
CP, % DM
Ash, % DM*
(table con’d)

m

400

62.2
15.2
50.1
8.8

400

_

Pooled
SET

Item
Carcass
Moisture, %c
Fat, %e
CP, % DM
Ash, % DM

0

_

I

Dark meat
Moisture, %b-eAe’f
71.7
75.7
79.7
Fat, %
5.8
5.6
5.8
CP, %DM*
63.8
66.1
67.2
Ash, % DM
3.8
3.5
3.8
*Data are means of two replicates of three broilers each.
bSex effect, P < .06.
eCr linear effect, P < .01.
dCr quadratic effect, P < .06.
°Sex x Cr linear effect, P < .04.
fSex x Cr quadratic effect, P < .03.

73.7
5.4
73.0
3.8

77.7
6.8
69.7
3.7

81.7
6.5
72.7
3.7

.5
.8
2.6
.1

oCJ\
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Experim ent’ 4

Supplemental dietary Cr did not affect (P > .10) growth performance (Table
6.11). Dietary Cr also did not affect (P > .10) glucose clearance during IVGTT or
IVICT or insulin clearance during IVGTT. The concentrations of glucose and
insulin across time for the IVGTT are shown in Figures 6.1 and 6.2, respectively.
The plot of glucose concentrations during IVICT is shown in Figure 6.3. Plasma
glucose was not different (P > .10) between dietary treatments during the LSMM.
However, plasma glucagon was lower (P < .04) in broilers fed CrPic during the
LSMM. The concentrations o f glucose and glucagon during LSMM are shown in
Figures 6.4 and 6.5, respectively.
Discussion
Supplemental dietary Cr affected ADG, ADFI, and gain:feed ratio
inconsistently in broilers in this investigation. Steele and Rosebrough (1979)
reported increased growth rate and feed efficiency of turkey poults fed diets
supplemented with 20 ppm Cr as Cr+J. Steele and Rosebrough (1981) also reported
increased growth rate, as well as increased lipogenesis, of poults fed 20 ppm Cr.
However, the increase in lipogenesis did not increase liver lipid content.
Rosebrough and Steele (1981) reported that 20 ppm dietary Cr as CrCl3 increased in
vitro incorporation of 14C-glucose into glycogen. Thus, apparently CrCl3 also is an

active source of Cr in poultry, as opposed to data from the pig (Page et al., 1990).
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Table 6.11. Effect of dietary chromium on growth performance, and glucose and insulin
clearance in broilers (Exp. 4)
Dietary Cr. ue/ke.
Pooled
Item_____________________________ 0
200_____ SD
Growth Performance
ADG, g
50.6
46.7
4.5
A D FI.g
135.1
134.0
6.2
Gain: feed
.374
.348
.023
Intravenous Glucose Tolerance Test
Glucose, 15 to 45 min
Clearance, %/min
2.59 (6)
Half-life, min
27.2(6)
Insulin, 15 to 30 min
Clearance, %/min
Half-life, min

10.92 (4)
6.96(4)

2.22 (7)
32.2(7)

8.43 (5)
9.37(5)

.37
5.0

2.96
4.05

Intravenous Insulin Challenge Test.
Glucose, 0 to 60 min
Clearance, %/min
1.50(5)
1.32(6)
.16
Half-life, min
47.0(5)
53.4(6)
5.6
*Growth performance data are from four replicates of five birds each (28 to 58 d of age;
avg. initial wt. = 976 g). Clearance rate and half-life data are from 11 wk old broilers;
number o f broilers is shown in parentheses.
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Figure 6.1. Effect of dietary chromium on glucose clearance in broilers during an
intravenous glucose tolerance test. Broilers were fed a com-soybean meal diet
without (O) or with (□) 200 n g Cr as chromium tripicolinate (CrPic)/kg diet. For
glucose clearance rate: pooled SD = .37; and for glucose half-life; pooled SD =
5.0.
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Figure 6.2. Effect of dietary chromium on insulin clearance in broilers during an
intravenous glucose tolerance test. Broilers were fed a com-soybean meal diet
without (O) or with (□) 200 Mg Cr as chromium tripicolinate (CrPic)/kg diet. For
insulin clearance rate: pooled SD = 2.96; and for glucose half-life; pooled SD =
4.05.
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Figure 6.3. Effect of dietary chromium on glucose clearance in broilers during an
intravenous insulin challenge test. Broilers were fed a corn-soybean meal diet
without (O) or with (□ ) 200 f*g Cr as chromium tripicolinate (CrPic)/kg diet. For
insulin clearance rate: pooled SD = . 16; and for glucose half-life; pooled SD =
5.6.
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Figure 6.4. Effect of dietary chromium on plasma glucose concentrations in broilers
during an intravenous least-sampling minimum model (LSMM) glucose tolerance
test. Broilers were fed a com-soybean meal diet without (O) or with (□ ) 200 t+g Cr
as chromium tripicolinate (CrPic)/kg diet.
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Figure 6.5. Effect of dietary chromium on plasma glucagon concentrations in
broilers during an intravenous least-sampling minimum model (LSMM) glucose
tolerance test. Broilers were fed a com-soybean meal diet without (O) or with (□)
200 Mg Cr as chromium tripicolinate (CrPic)/kg diet.

Page et al. (1993a) reported increased, decreased, and no change in ADG of
pigs fed CrPic. Other investigators have reported inconsistent (yet primarily a lack
of) effects of dietary Cr on growth performance of pigs (Boleman et al., 1995; Page
et al., 1993a,b; Renteria and Cuaron, 1993), lambs (Gentry et al., 1995; Kitchalong
et al., 1995), calves (Bunting et al,, 1994) and steers (Claeys et al., 1994).
However, it may be inappropriate to compare the results of other investigators with
our data because of the dramatic differences in length of treatment, physiological
and chronological age o f the animals, as well as species differences. These same
factors may partially explain why we were not able to detect an increase in N
balance, in Exp. 1, as reported by Britton et al (1968) in lambs. Kitchalong et al.
(1993) also reported no effect of CrPic on N balance of lambs.
Supplemental dietary Cr did not affect the percentage of CP, moisture, or
ether extract in breast and leg muscle samples in Exp. 1. This lack of effect on meat
characteristics is in agreement with other data from pigs (Page et al., 1992b).
However, Data from Exp. 2 and 3 indicate that Cr is affecting the composition of
body components. The increased weight of tire ventriculus, a highly muscular
organ, follows the increased muscling reported by other investigators in pigs
(Boleman et al., 1995; Lindemann et al., 1995; Mooney and Cromwell, 1995; Page
et al., 1993). Furthermore, in Exp. 3, dietary Cr supplementation increased CP in
the carcass. Recall that the carcass did not contain the breast meat or the right leg
and thigh meal. This suggests that dietary Cr may have subtle effects on multiple

carcass components or that Cr is affecting some individual carcass component that
was not measured. In contrast to Exp. 1, in Exp. 3 the percentage of moisture in
the dark meat was increased by dietary Cr supplementation. The positive association
o f moisture content with protein content and negative association of moisture content
with fat content suggest that Cr may be increasing total carcass protein. In addition,
Cr supplementation in Exp. 3 resulted in a reduction in abdominal fat pad weight,
which is correlated with total carcass fat content. Thus, Cr may be affecting fat
deposition and(or) protein deposition. The data of Mooney and Cromwell (1995)
suggests that both protein and fat deposition arc affected simultaneously. Similarly,
the increased carcass ash (Exp. 2) is in agreement with data from pigs (Boleman et
al., 1995; Mooney and Cromwell, 1995). Thus, it appears that CrPic may be
influencing the total amounts of body fat (less) and body CP (more) in broilers. The
current data suggest that long-term feeding is more beneficial than short-term
feeding. This is the opposite response that has been reported for one study with pigs
(Boleman et al., 1995). However, it is wise to use caution when comparing these
results. To more accurately describe the response to length of feeding Cr, broilers
should be fed Cr different lengths of time, but all birds should be fed to a
conventional finished broiler end point.
The influence o f Cr on insulin function and glucose status of mammals is well
documented; however, the importance o f insulin in the metabolism of the chicken is
not well established. The effects of Cr on the body composition of broiler chicks
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may implicate the importance of insulin in avian metabolism or it is possible that Cr
is mediating its effects via other and/or additional mechanisms from insulin.
Touchbum et al. (1981) reported a relationship between plasma glucose and insulin
and body fat content of broilers. That is, broilers that have been selected for
increased body fat content have lower fasting glucose and higher fasting insulin
concentrations (Touchbum et al., 1981). However, in commercial broilers, such as
those we used, that historically have been selected for increased rate of BW gain
(and incidentally increased fat), it is not clear if the relationship between insulin and
glucose and body tat remains. In Exp. 3, in the fasted condition, broilers had
increased plasma insulin due to Cr supplementation, but no change was seen in
glucose concentration. If the relationship as described by Touchbum et al. (1981) is
true then it would follow that the broilers given supplemental Cr would contain more
fat. However, the data do not support this conclusion. Due to the lack of effect of
dietary Cr on glucose and insulin clearance in this investigation, it is not possible to
draw unequivocal conclusions regarding the relationship between dietary Cr
supplementation and plasma glucose and plasma insulin and body composition.
It is not possible to draw many conclusions from the LSMM data. However,
it is interesting that the dramatic rise in glucagon that occurred in both treatment
groups following the insulin infusion was not capable of inducing a concomitant
increase in blood glucose. In addition, the overall lower level of plasma glucagon
observed in the broilers fed Cr is perplexing. Glucagon is highly lipolytic in the
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avian species. Lower plasma glucagon would imply that the birds fed Cr may
deposit more fat; however, the carcass composition data do not support this.
The trend toward increased protein and decreased fat in the carcass of broilers
indicates that Cr as CrPic may be of economic importance in the poultry industry.
Providing the human population a healthier (less fat) product is a desirable goal from
both a human and animal nutritionist viewpoint
Implications
Dietary chromium may affect metabolism of broilers and thereby also affect
body composition. Increased protein and decreased fat content of chicken meat
would be of considerable benefit to the world human population that consumes the
meat. However, conduction o f conventional floor pen studies and industry carcass
measurements would better quantify the effect of dietary chromium on the body
composition of chickens. Dietary chromium supplementation may be a means of
decreasing fat content and increasing protein content of broilers.

CHAPTER VII
OVERALL SUMMARY AND CONCLUSIONS

The results of the first experiment indicate that the puiported effects of dietary
Cr supplementation on body composition are not always evident. Dietary Cr, in
both inorganic and organic forms, did not decrease tenth rib fat thickness nor
increase longissimus muscle area, as has been reported by other investigators.
However, other researchers have reported increased carcass protein and decreased
carcass fat in pigs fed supplemental Cr when linear carcass measurements (i.e., tenth
rib fat thickness and longissimus muscle area) were not affected. Only linear
carcass measurements were taken in experiment one; therefore, subtle changes in
carcass composition may have occurred. The reasons for a less dramatic effect,
perhaps, on carcass composition are not known. Some investigators have
hypothesized that the level of stress, genotype differences, or Cr status may be
responsible for the different results obtained from dietary Cr supplementation. The
second experiment suggested that dietary Cr supplementation as Cr chloride
hexahydrate, Cr nicotinate, or Cr tripicolinate did not affect glucose and insulin
clearance in pigs given intravenous glucose tolerance tests or intravenous insulin
challenge tests. Thus, again the reason for the discrepant results between
experiment two and other experiments with Cr tripicolinate from the same
laboratory are not known. In experiment three, decreased pen size and decreased
dietary crude protein concentration were not effective in inducing a Cr effect on
118
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linear carcass traits of growing-finishing pigs. The following are possible reasons:
1) the chronic effect of decreased pen size and decreased dietary crude protein were
not effective as stressors, 2) the pigs were able to adapt to the stress, or 3) the
effects o f dietary Cr are not mediated through stress-related mechanisms. In
experiment four, body composition of broiler chickens was affected by dietary Cr
supplementation. Although the data are inconclusive, they suggest that dietary Cr
supplementation as Cr tripicolinate is effective in increasing carcass crude protein
and decreasing carcass fat content. It is not clear if the effects on body composition
were mediated through glucose or insulin utilization. Data collected under practical
growing conditions with industry carcass measurements would be of great benefit in
clarifying the effectiveness of dietary Cr in modulating carcass composition of
broilers. The conditions under which dietary Cr supplementation is beneficial to
livestock species and thus the livestock industry need to be better characterized in
order to provide firmer recommendations on the use o f dietary Cr.
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